COVER
COVER - shares | 3 Months Ended | |
Sep. 30, 2023 | Oct. 31, 2023 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Sep. 30, 2023 | |
Document Transition Report | false | |
Entity File Number | 001-35964 | |
Entity Registrant Name | COTY INC. | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 13-3823358 | |
Entity Address, Address Line One | 350 Fifth Avenue, | |
Entity Address, City or Town | New York, | |
Entity Address, State or Province | NY | |
Entity Address, Postal Zip Code | 10118 | |
City Area Code | 212 | |
Local Phone Number | 389-7300 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth | false | |
Entity Shell Company | false | |
Title of 12(b) Security | Class A Common Stock, $0.01 par value | |
Trading Symbol | COTY | |
Security Exchange Name | NYSE | |
Entity Common Stock, Shares Outstanding (in shares) | 891,671,042 | |
Amendment Flag | false | |
Entity Central Index Key | 0001024305 | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q1 | |
Current Fiscal Year End Date | --06-30 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Income Statement [Abstract] | ||
Net revenues | $ 1,641.4 | $ 1,390 |
Cost of sales | 599.5 | 501.3 |
Gross profit | 1,041.9 | 888.7 |
Selling, general and administrative expenses | 767.4 | 670.7 |
Amortization expense | 48.6 | 47.3 |
Restructuring costs | 28.4 | (1.2) |
Operating income | 197.5 | 171.9 |
Interest expense, net | 69.8 | 65.9 |
Other expense (income), net | 76.6 | (98.2) |
Income before income taxes | 51.1 | 204.2 |
Provision for income taxes | 40.9 | 69.7 |
Net income | 10.2 | 134.5 |
Net income attributable to noncontrolling interests | 1.1 | 0 |
Net income attributable to redeemable noncontrolling interests | 7.5 | 5.9 |
Net income attributable to Coty Inc. | 1.6 | 128.6 |
Amounts attributable to Coty Inc. | ||
Net income attributable to Coty Inc. | 1.6 | 128.6 |
Convertible Series B Preferred Stock dividends | (3.3) | (3.3) |
Net (loss) income attributable to common stockholders | (1.7) | 125.3 |
Net (loss) income attributable to common stockholders | $ (1.7) | $ 125.3 |
Earnings per common share: | ||
Earnings per common share - basic (in dollars per share) | $ 0 | $ 0.15 |
Earnings per common share - diluted (in dollars per share) | $ 0 | $ 0.15 |
Weighted-average common shares outstanding: | ||
Basic (in shares) | 854.3 | 842 |
Diluted (in shares) | 854.3 | 882.2 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 10.2 | $ 134.5 |
Other comprehensive income (loss): | ||
Foreign currency translation adjustment | (114.5) | (264.1) |
Net unrealized derivative gain (loss) on cash flow hedges, net of taxes of $(0.7) and $(0.5) during the three months ended, respectively | 1.5 | 0.9 |
Pension and other post-employment benefits adjustment, net of tax of $0.9 and $0.8 during the three months ended, respectively | (2.1) | (3.2) |
Total other comprehensive loss, net of tax | (115.1) | (266.4) |
Comprehensive loss | (104.9) | (131.9) |
Comprehensive income attributable to noncontrolling interests: | ||
Net income | 1.1 | 0 |
Total comprehensive income attributable to noncontrolling interests | 1.1 | 0 |
Comprehensive income attributable to redeemable noncontrolling interests: | ||
Net income | 7.5 | 5.9 |
Foreign currency translation adjustment | (0.1) | (0.2) |
Total comprehensive income attributable to noncontrolling interests | 7.4 | 5.7 |
Comprehensive loss attributable to Coty Inc. | $ (113.4) | $ (137.6) |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parentheticals) - USD ($) $ in Millions | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Statement of Comprehensive Income [Abstract] | ||
Change in derivative gains on cash flow hedges, tax expense (benefit) | $ (0.7) | $ (0.5) |
Pension and other post-employment benefits (losses), tax expense (benefit) | $ 0.9 | $ 0.8 |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Sep. 30, 2023 | Jun. 30, 2023 |
Current assets: | ||
Cash and cash equivalents | $ 280 | $ 246.9 |
Restricted cash | 37.7 | 36.9 |
Trade receivables—less allowances of $23.5 and $23.2, respectively | 534.9 | 360.9 |
Inventories | 845.4 | 853.4 |
Prepaid expenses and other current assets | 545.5 | 553.6 |
Total current assets | 2,243.5 | 2,051.7 |
Property and equipment, net | 689.5 | 712.9 |
Goodwill | 3,927.5 | 3,987.9 |
Other intangible assets, net | 3,688.4 | 3,798 |
Equity investments | 1,072.1 | 1,068.9 |
Operating lease right-of-use assets | 281.1 | 286.7 |
Deferred income taxes | 571.2 | 589.9 |
Other noncurrent assets | 143.6 | 165.6 |
TOTAL ASSETS | 12,616.9 | 12,661.6 |
Current liabilities: | ||
Accounts payable | 1,375.4 | 1,444.7 |
Accrued expenses and other current liabilities | 1,227 | 1,042 |
Short-term debt and current portion of long-term debt | 40.8 | 57.9 |
Current operating lease liabilities | 59.9 | 65.6 |
Income and other taxes payable | 125 | 126.6 |
Total current liabilities | 2,828.1 | 2,736.8 |
Long-term debt, net | 4,095.4 | 4,178.2 |
Long-term operating lease liabilities | 244.3 | 247.5 |
Pension and other post-employment benefits | 273 | 280.7 |
Deferred income taxes | 682.9 | 659.7 |
Other noncurrent liabilities | 343.5 | 325.4 |
Total liabilities | 8,467.2 | 8,428.3 |
COMMITMENTS AND CONTINGENCIES (See Note 17) | ||
CONVERTIBLE SERIES B PREFERRED STOCK, $0.01 par value; 1.0 shares authorized; 0.1 and 0.1 issued and outstanding at September 30, 2023 and June 30, 2023, respectively | 142.4 | 142.4 |
REDEEMABLE NONCONTROLLING INTERESTS | 98.6 | 93.5 |
EQUITY: | ||
Preferred Stock, $0.01 par value; 20.0 shares authorized, 1.0 issued and outstanding at September 30, 2023 and June 30, 2023 | 0 | 0 |
Class A Common Stock, $0.01 par value; 1,250.0 shares authorized, 954.5 and 919.3 issued and 888.0 and 852.8 outstanding at September 30, 2023 and June 30, 2023, respectively | 9.5 | 9.1 |
Stock to be issued | 31.5 | 0 |
Additional paid-in capital | 11,238.8 | 10,898.6 |
Receivable from sale of stock | (348.5) | 0 |
Accumulated deficit | (4,986.3) | (4,987.9) |
Accumulated other comprehensive loss | (777.4) | (662.4) |
Treasury stock—at cost, shares: 66.5 and 66.5 at September 30, 2023 and June 30, 2023, respectively | (1,446.3) | (1,446.3) |
Total Coty Inc. stockholders’ equity | 3,721.3 | 3,811.1 |
Noncontrolling interests | 187.4 | 186.3 |
Total equity | 3,908.7 | 3,997.4 |
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY | $ 12,616.9 | $ 12,661.6 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($) $ in Millions | Sep. 30, 2023 | Jun. 30, 2023 |
Statement of Financial Position [Abstract] | ||
Trade receivables, allowances | $ 23.5 | $ 23.2 |
Convertible Series B preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Convertible Series B preferred stock, shares authorized (in shares) | 1,000,000 | 1,000,000 |
Convertible Series B preferred stock, shares issued (in shares) | 100,000 | 100,000 |
Convertible Series B preferred stock, shares outstanding (in shares) | 100,000 | 100,000 |
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized (in shares) | 20,000,000 | 20,000,000 |
Preferred stock, shares issued (in shares) | 1,000,000 | 1,000,000 |
Preferred stock, shares outstanding (in shares) | 1,000,000 | 1,000,000 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in shares) | 1,250,000,000 | 1,250,000,000 |
Common stock, shares issued (in shares) | 954,500,000 | 919,300,000 |
Common stock, shares outstanding (in shares) | 888,000,000 | 852,800,000 |
Treasury stock, at cost, shares (in shares) | 66,500,000 | 66,500,000 |
CONDENSED CONSOLIDATED STATEM_4
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($) shares in Millions, $ in Millions | Total | Total Coty Inc. Stockholders’ Equity | Preferred Stock | Common Stock | Common Stock Class A Common Stock | Stock to be issued | Additional Paid-in Capital | Receivable from sale of stock | (Accumulated Deficit) | Accumulated Other Comprehensive (Loss) Income | Treasury Stock | Noncontrolling Interests |
Beginning balance (in shares) at Jun. 30, 2022 | 1.5 | |||||||||||
Balance, beginning of period at Jun. 30, 2022 | $ 3,345.8 | $ 3,154.5 | $ 0 | $ 9 | $ 10,805.8 | $ (5,496.1) | $ (717.9) | $ (1,446.3) | $ 191.3 | |||
Beginning balance (in shares) at Jun. 30, 2022 | 905.5 | |||||||||||
Beginning balance (in shares) at Jun. 30, 2022 | 66.3 | |||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||
Exercise of employee stock options and restricted stock units (in shares) | 10.2 | |||||||||||
Reacquired Class A Common Stock for employee taxes (in shares) | 0.1 | |||||||||||
Shares withheld for employee taxes | (1.1) | (1.1) | (1.1) | |||||||||
Share-based compensation expense | 31.4 | 31.4 | 31.4 | |||||||||
Equity Investment contribution for share-based compensation | 1.7 | 1.7 | 1.7 | |||||||||
Dividends Accrued - Convertible Series B Preferred Stock | (3.3) | (3.3) | (3.3) | |||||||||
Net income (loss) | 128.6 | 128.6 | 128.6 | |||||||||
Other comprehensive loss | (266.2) | (266.2) | (266.2) | |||||||||
Adjustment of redeemable noncontrolling interests to redemption value | 6.2 | 6.2 | 6.2 | |||||||||
Ending balance (in shares) at Sep. 30, 2022 | 1.5 | |||||||||||
Ending balance at Sep. 30, 2022 | 3,243.1 | 3,051.8 | $ 0 | $ 9 | 10,840.7 | (5,367.5) | (984.1) | $ (1,446.3) | 191.3 | |||
Ending balance (in shares) at Sep. 30, 2022 | 915.7 | |||||||||||
Ending balance (in shares) at Sep. 30, 2022 | 66.4 | |||||||||||
Balance, beginning of period at Jun. 30, 2022 | 69.8 | |||||||||||
Balance, beginning of period at Jun. 30, 2022 | 142.4 | |||||||||||
Redeemable Noncontrolling Interests | ||||||||||||
Dividends Accrued - Convertible Series B Preferred Stock | 3.3 | |||||||||||
Dividends Paid - Convertible Series B Preferred Stock | (3.3) | |||||||||||
Net income (loss) | 5.9 | |||||||||||
Other comprehensive loss | (0.2) | |||||||||||
Adjustment of redeemable noncontrolling interests to redemption value | (6.2) | |||||||||||
Balance, end of period at Sep. 30, 2022 | 69.3 | |||||||||||
Balance, end of period at Sep. 30, 2022 | $ 142.4 | |||||||||||
Beginning balance (in shares) at Jun. 30, 2023 | 1 | 1 | ||||||||||
Balance, beginning of period at Jun. 30, 2023 | $ 3,997.4 | 3,811.1 | $ 0 | $ 9.1 | $ 0 | 10,898.6 | $ 0 | (4,987.9) | (662.4) | $ (1,446.3) | 186.3 | |
Beginning balance (in shares) at Jun. 30, 2023 | 919.3 | 919.3 | ||||||||||
Beginning balance (in shares) at Jun. 30, 2023 | 66.5 | 66.5 | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||||
Issuance of common stock in connection with global offering, net of offering costs (in shares) | 30 | |||||||||||
Issuance of common stock in connection with global offering, net of offering costs | $ (5.5) | $ 0.3 | 31.5 | 311.2 | (348.5) | |||||||
Exercise of employee stock options and restricted stock units (in shares) | 5.2 | |||||||||||
Exercise of employee stock options and restricted stock units | $ 0.1 | (0.1) | ||||||||||
Shares withheld for employee taxes | (0.8) | (0.8) | (0.8) | |||||||||
Share-based compensation expense | 30.2 | 30.2 | 30.2 | |||||||||
Equity Investment contribution for share-based compensation | 0.7 | 0.7 | 0.7 | |||||||||
Dividends Accrued - Convertible Series B Preferred Stock | (3.3) | (3.3) | (3.3) | |||||||||
Net income (loss) | 2.7 | 1.6 | 1.6 | 1.1 | ||||||||
Other comprehensive loss | (115) | (115) | (115) | |||||||||
Adjustment of redeemable noncontrolling interests to redemption value | $ 2.3 | 2.3 | 2.3 | |||||||||
Ending balance (in shares) at Sep. 30, 2023 | 1 | 1 | ||||||||||
Ending balance at Sep. 30, 2023 | $ 3,908.7 | $ 3,721.3 | $ 0 | $ 9.5 | $ 31.5 | $ 11,238.8 | $ (348.5) | $ (4,986.3) | $ (777.4) | $ (1,446.3) | $ 187.4 | |
Ending balance (in shares) at Sep. 30, 2023 | 954.5 | 954.5 | ||||||||||
Ending balance (in shares) at Sep. 30, 2023 | 66.5 | 66.5 | ||||||||||
Balance, beginning of period at Jun. 30, 2023 | $ 93.5 | |||||||||||
Balance, beginning of period at Jun. 30, 2023 | 142.4 | |||||||||||
Redeemable Noncontrolling Interests | ||||||||||||
Dividends Accrued - Convertible Series B Preferred Stock | 3.3 | |||||||||||
Dividends Paid - Convertible Series B Preferred Stock | (3.3) | |||||||||||
Net income (loss) | 7.5 | |||||||||||
Other comprehensive loss | (0.1) | |||||||||||
Adjustment of redeemable noncontrolling interests to redemption value | (2.3) | |||||||||||
Balance, end of period at Sep. 30, 2023 | 98.6 | |||||||||||
Balance, end of period at Sep. 30, 2023 | $ 142.4 |
CONDENSED CONSOLIDATED STATEM_5
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||
Net income | $ 10.2 | $ 134.5 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization | 106.8 | 106.6 |
Non-cash lease expense | 15.8 | 16 |
Deferred income taxes | 22.8 | 59.5 |
Provisions (releases) for bad debts | 1 | (3.3) |
Provision for pension and other post-employment benefits | 2.5 | 2.3 |
Share-based compensation | 29.7 | 31.1 |
(Gains) losses on disposals of long-term assets, net | (1) | 2.4 |
Realized and unrealized gains from equity investments, net | (3.2) | (134.1) |
Foreign exchange effects | 8.2 | 3.8 |
Unrealized losses on forward repurchase contracts, net | 65.4 | 45.2 |
Other | 11.5 | 10.5 |
Change in operating assets and liabilities | ||
Trade receivables | (190.8) | (133.8) |
Inventories | (9.9) | (42.1) |
Prepaid expenses and other current assets | (47.4) | (58.4) |
Accounts payable | (22.4) | 50.6 |
Accrued expenses and other current liabilities | 183.8 | 119.1 |
Operating lease liabilities | (16) | (18) |
Income and other taxes payable | 10.3 | 10.4 |
Other noncurrent assets | (9.4) | (20.4) |
Other noncurrent liabilities | 18.3 | (18.7) |
Net cash provided by operating activities | 186.2 | 163.2 |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||
Capital expenditures | (62.2) | (75) |
Net cash used in investing activities | (62.2) | (75) |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||
Proceeds from revolving loan facilities | 834 | 220.7 |
Repayments of revolving loan facilities | (962) | (208.9) |
Proceeds from issuance of other long-term debt | 1,284.3 | 0 |
Repayments of term loans and other long-term debt | (1,186.6) | (5.6) |
Dividend payments on Class A Common Stock and Class B Preferred Stock | (3.3) | (3.6) |
Net payments of foreign currency contracts | (4) | (89.5) |
Payments related to forward repurchase contracts | (3.9) | 0 |
Payment of deferred financing fees | (36) | 0 |
All other | (1.1) | (0.9) |
Net cash used in financing activities | (78.6) | (87.8) |
EFFECT OF EXCHANGE RATES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH | (11.5) | (13.1) |
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | 33.9 | (12.7) |
CASH, CASH EQUIVALENTS AND RESTRICTED CASH—Beginning of period | 283.8 | 263.8 |
CASH, CASH EQUIVALENTS AND RESTRICTED CASH—End of period | 317.7 | 251.1 |
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION: | ||
Cash paid during the period for interest | 35.4 | 32.9 |
Net cash paid for income taxes | 16.1 | 5.6 |
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: | ||
Accrued capital expenditure additions | 85.1 | 60.5 |
Receivable from issuance of common stock, net of offering costs | $ 343 | $ 0 |
DESCRIPTION OF BUSINESS
DESCRIPTION OF BUSINESS | 3 Months Ended |
Sep. 30, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
DESCRIPTION OF BUSINESS | DESCRIPTION OF BUSINESS Coty Inc. and its subsidiaries (collectively, the “Company” or “Coty”) manufacture, market, sell and distribute branded beauty products, including fragrances, color cosmetics and skin & body related products throughout the world. Coty is a global beauty company with a rich entrepreneurial history and an iconic portfolio of brands. The Company operates on a fiscal year basis with a year-end of June 30. Unless otherwise noted, any reference to a year preceded by the word “fiscal” refers to the fiscal year ended June 30 of that year. For example, references to “fiscal 2024” refer to the fiscal year ending June 30, 2024. When used in this Quarterly Report on Form 10-Q, the term “includes” and “including” means, unless the context otherwise indicates, including without limitation. The Company’s sales generally increase during the second fiscal quarter as a result of increased demand associated with the winter holiday season. Financial performance, working capital requirements, sales, cash flows and borrowings generally experience variability during the three to six months preceding the holiday season. Product innovations, new product launches and the size and timing of orders from the Company’s customers may also result in variability. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The unaudited interim Condensed Consolidated Financial Statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and include the Company’s consolidated domestic and international subsidiaries. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, these unaudited interim Condensed Consolidated Financial Statements and accompanying footnotes should be read in conjunction with the Company’s Consolidated Financial Statements as of and for the year ended June 30, 2023. In the opinion of management, all adjustments, of a normal recurring nature, considered necessary for a fair presentation have been included in the Condensed Consolidated Financial Statements. The results of operations for the three months ended September 30, 2023 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending June 30, 2024. All dollar amounts (other than per share amounts) in the following discussion are in millions of United States (“U.S.”) dollars, unless otherwise indicated. Restricted Cash Restricted cash represents funds that are not readily available for general purpose cash needs due to contractual limitations. Restricted cash is classified as a current or long-term asset based on the timing and nature of when or how the cash is expected to be used or when the restrictions are expected to lapse. As of September 30, 2023 and June 30, 2023, the Company had restricted cash of $37.7 and $36.9, respectively, included in Restricted cash in the Condensed Consolidated Balance Sheets. The Restricted cash balance as of September 30, 2023 primarily provides collateral for certain bank guarantees on rent, customs and duty accounts and also consists of collections on factored receivables that remain unremitted to the factor as of September 30, 2023. Restricted cash is included as a component of Cash, cash equivalents and restricted cash in the Condensed Consolidated Statement of Cash Flows. Equity Investments The Company elected the fair value option to account for its investment in Rainbow JVCO LTD and subsidiaries (together, "Wella" or the “Wella Company”) to align with the Company’s strategy for this investment. The fair value is updated on a quarterly basis. The investment is classified within Level 3 in the fair value hierarchy because the Company estimates the fair value of the investment using a combination of the income approach, the market approach and private transactions, when applicable. Changes in the fair value of equity investment under the fair value option are recorded in Other expense (income), net within the Condensed Consolidated Statements of Operations (see Note 6—Equity Investments). Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the period reported. Significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, the net realizable value of inventory, the fair value of equity investments, the assessment of goodwill, other intangible assets and long-lived assets for impairment and income taxes. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates and assumptions resulting from continuing changes in the economic environment will be reflected in the Condensed Consolidated Financial Statements in future periods. Tax Information The effective income tax rate for the three months ended September 30, 2023 and 2022 was 80.0% and 34.1%, respectively. The change in the effective tax rate for the three months ended September 30, 2023, as compared with the three months ended September 30, 2022, was primarily due to an expense of $24.3 in the current period recognized on the revaluation of the Company's deferred tax liabilities due to a tax rate increase enacted in Switzerland. The effective income tax rates vary from the U.S. federal statutory rate of 21% due to the effect of (i) jurisdictions with different statutory rates, including impacts of rate changes, (ii) adjustments to the Company’s unrealized tax benefits (“UTBs”) and accrued interest, (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes. As of September 30, 2023 and June 30, 2023, the gross amount of UTBs was $233.1 and $235.5, respectively. As of September 30, 2023, the total amount of UTBs that, if recognized, would impact the effective income tax rate is $183.8. As of September 30, 2023 and June 30, 2023, the liability associated with UTBs, including accrued interest and penalties, was $218.8 and $218.6, respectively, which was recorded in Income and other taxes payable and Other noncurrent liabilities in the Condensed Consolidated Balance Sheets. The total interest and penalties recorded in the Condensed Consolidated Statements of Operations related to UTBs was $1.3 for the three months ended September 30, 2023 and 2022. The total gross accrued interest and penalties recorded in the Condensed Consolidated Balance Sheets as of September 30, 2023 and June 30, 2023 was $34.4 and $33.1, respectively. On the basis of the information available as of September 30, 2023, it is reasonably possible that a decrease of up to $11.3 in UTBs may occur within twelve months as a result of projected resolutions of global tax examinations and a potential lapse of the applicable statutes of limitations. Russia Market Exit In connection with the Company’s Board of Director’s decision to wind down operations in Russia, the Company recognized total pre-tax losses in the Condensed Consolidated Statements of Operations of $0.1 and $1.1, respectively, in the three months ended September 30, 2023 and 2022. The Company anticipates that it will incur an immaterial amount of additional costs through completion of the wind down. Additionally, management anticipates derecognizing the cumulative translation adjustment balance pertaining to the Russian subsidiary. The Company has substantially completed its commercial activities in Russia. However, the Company anticipates that the process related to the liquidation of the Russian legal entity will take an extended period of time. Recent Accounting Pronouncements No new accounting pronouncements issued but not yet adopted are expected to have a material impact on the Company's unaudited Condensed Consolidated Financial Statements. |
SEGMENT REPORTING
SEGMENT REPORTING | 3 Months Ended |
Sep. 30, 2023 | |
Segment Reporting [Abstract] | |
SEGMENT REPORTING | SEGMENT REPORTING Operating and reportable segments (referred to as “segments”) reflect the way the Company is managed and for which separate financial information is available and evaluated regularly by the Company's chief operating decision maker ("CODM") in deciding how to allocate resources and assess performance. The Company has designated its Chief Executive Officer ("CEO") as the CODM. Certain income and shared costs and the results of corporate initiatives are managed by Corporate. Corporate primarily includes stock compensation expense, restructuring and realignment costs, costs related to acquisition, divestiture and early license termination activities, and impairments of long-lived assets, goodwill and intangibles that are not attributable to ongoing operating activities of the segments. Corporate costs are not used by the CODM to measure the underlying performance of the segments. With the exception of goodwill, the Company does not identify or monitor assets by segment. The Company does not present assets by reportable segment since various assets are shared between reportable segments. The allocation of goodwill by segment is presented in Note 7—Goodwill and Other Intangible Assets, net. Three Months Ended SEGMENT DATA 2023 2022 Net revenues: Prestige $ 1,064.7 $ 863.4 Consumer Beauty 576.7 526.6 Total $ 1,641.4 $ 1,390.0 Operating income (loss): Prestige 221.6 170.3 Consumer Beauty 32.0 32.0 Corporate (56.1) (30.4) Total $ 197.5 $ 171.9 Reconciliation: Operating income 197.5 171.9 Interest expense, net 69.8 65.9 Other expense (income), net 76.6 (98.2) Income before income taxes $ 51.1 $ 204.2 Presented below are the percentage of revenues associated with the Company’s product categories: Three Months Ended PRODUCT CATEGORY 2023 2022 Fragrance 63.3 % 59.3 % Color Cosmetics 24.6 27.7 Body Care, Skin & Other 12.1 13.0 Total 100.0 % 100.0 % |
RESTRUCTURING COSTS
RESTRUCTURING COSTS | 3 Months Ended |
Sep. 30, 2023 | |
Restructuring and Related Activities [Abstract] | |
RESTRUCTURING COSTS | RESTRUCTURING COSTS Restructuring costs for the three months ended September 30, 2023 and 2022 are presented below: Three Months Ended 2023 2022 2024 Restructuring Actions $ 28.6 $ — Transformation Plan and Other (0.2) (1.2) Total $ 28.4 $ (1.2) 2024 Restructuring Actions During fiscal 2024, the Company began the implementation of continued process optimization and improved technology support for certain areas (the "2024 Restructuring Actions"). The Company expects to incur approximately $30.0 related to employee termination benefits under this plan. Of the expected costs, the Company has incurred cumulative restructuring charges of $29.9 related to approved initiatives through September 30, 2023, which have been recorded in Corporate. The Company recognized expenses of $28.6 and $0.0 for the three months ended September 30, 2023 and 2022, respectively, which have been recorded in Corporate. The related liability balances were $29.9 (including certain actions that were accrued during fiscal 2023) and $0.0 at September 30, 2023 and June 30, 2023 respectively. The Company currently estimates that the total remaining accrual of $29.9 will result in cash expenditures of approximately $6.8, $9.3 and $13.8 in fiscal 2024, 2025 and thereafter, respectively. Transformation Plan and Other The Company previously announced a four-year plan to drive substantial improvement and optimization in the Company's businesses, under which the Company expected to incur restructuring and related costs (the “Transformation Plan”), which is now substantially complete. Of the expected costs, the Company has incurred cumulative restructuring charges of $215.3 related to approved initiatives through September 30, 2023, which have been recorded in Corporate. The Company recognized income of $0.2 and $1.2 for the period ended September 30, 2023 and 2022, respectively. The related liability balances were $7.5 and $10.0 at September 30, 2023 and June 30, 2023 respectively. The Company currently estimates that the total remaining accrual of $7.5 will result in cash expenditures of approximately $6.1, $1.3 and $0.1 in fiscal 2024, 2025 and thereafter, respectively. |
INVENTORIES
INVENTORIES | 3 Months Ended |
Sep. 30, 2023 | |
Inventory Disclosure [Abstract] | |
INVENTORIES | INVENTORIES Inventories as of September 30, 2023 and June 30, 2023 are presented below: September 30, June 30, Raw materials $ 215.5 $ 224.1 Work-in-process 13.9 15.6 Finished goods 616.0 613.7 Total inventories $ 845.4 $ 853.4 |
EQUITY INVESTMENTS
EQUITY INVESTMENTS | 3 Months Ended |
Sep. 30, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
EQUITY INVESTMENTS | EQUITY INVESTMENTS The Company's equity investments, classified as Equity investments in the Condensed Consolidated Balance Sheets are represented by the following: September 30, June 30, Equity method investments: KKW Holdings (a) $ 8.1 $ 8.9 Equity investments at fair value: Wella (b) 1,064.0 1,060.0 Total equity investments $ 1,072.1 $ 1,068.9 (a) On January 4, 2021, the Company completed its purchase of 20% of the outstanding equity of KKW Holdings. The Company accounts for this minority investment under the equity method, given it has the ability to exercise significant influence over, but not control, the investee. The carrying value of the Company’s investment includes basis differences allocated to amortizable intangible assets. The Company recognized $0.8 and $0.9, respectively, during the three months ended September 30, 2023 and 2022 representing its share of the investee’s net loss in Other expense (income), net within the Condensed Consolidated Statements of Operations. (b) As of September 30, 2023 and June 30, 2023, the Company's stake in Wella was 25.9%. On July 18, 2023, the Company announced that it had entered into a binding letter of intent to sell a 3.6% stake in Wella to an investment firm for $150.0. Subsequently, the Company and investment firm mutually agreed not to pursue the proposed transaction and entered into a termination letter in October 2023. The following table presents summarized financial information of the Company’s equity method investees for the period ending September 30, 2023. Amounts presented represent combined totals at the investee level and not the Company’s proportionate share: Three Months Ended 2023 2022 Summarized Statements of Operations information: Net revenues $ 637.3 $ 596.6 Gross profit 426.8 394.6 Operating income 44.9 61.0 (Loss) income before income taxes (6.8) 20.0 Net (loss) income (16.7) 16.0 The following table summarizes movements in equity investments with fair value option that are classified within Level 3 for the period ended September 30, 2023. There were no internal movements to or from Level 3 and Level 1 or Level 2 for the period ended September 30, 2023. Equity investments at fair value: Balance as of June 30, 2023 $ 1,060.0 Total gains included in earnings 4.0 Balance as of September 30, 2023 $ 1,064.0 Level 3 significant unobservable inputs sensitivity The following table summarizes the significant unobservable inputs used in Level 3 valuation of the Company's investments carried at fair value as of September 30, 2023. Included in the table are the inputs or range of possible inputs that have an effect on the overall valuation of the financial instruments. Fair value Valuation technique Unobservable Range Equity investments at fair value $ 1,064.0 Discounted cash flows Discount rate 10.50% (a) Growth rate 1.8% - 9.2% (a) Market multiple Revenue multiple 2.1x – 2.3x (b) EBITDA multiple 10.4x – 13.9x (b) (a) The primary unobservable inputs used in the fair value measurement of the Company's equity investments with fair value option, when using a discounted cash flow method, are the discount rate and revenue growth rate. Significant increases (decreases) in the discount rate in isolation would result in a significantly lower (higher) fair value measurement. The Company estimates the discount rate based on the investees' projected cost of equity and debt. The revenue growth rate is forecasted for future years by the investee based on their best estimates. Significant increases (decreases) in the revenue growth rate in isolation would result in a significantly higher (lower) fair value measurement. (b) The primary unobservable inputs used in the fair value measurement of the Company's equity investments with fair value option, when using a market multiple method, are the revenue multiple and EBITDA multiple. Significant increases (decreases) in the revenue multiple or EBITDA multiple in isolation would result in a significantly higher (lower) fair value measurement. The market multiples are derived from a group of guideline public companies. |
GOODWILL AND OTHER INTANGIBLE A
GOODWILL AND OTHER INTANGIBLE ASSETS, NET | 3 Months Ended |
Sep. 30, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
GOODWILL AND OTHER INTANGIBLE ASSETS, NET | GOODWILL AND OTHER INTANGIBLE ASSETS, NET Goodwill Goodwill as of September 30, 2023 and June 30, 2023 is presented below: Prestige Consumer Beauty Total Gross balance at June 30, 2023 $ 6,279.2 $ 1,748.8 $ 8,028.0 Accumulated impairments (3,110.3) (929.8) (4,040.1) Net balance at June 30, 2023 $ 3,168.9 $ 819.0 $ 3,987.9 Changes during the period ended September 30, 2023 Foreign currency translation (48.1) (12.3) (60.4) Gross balance at September 30, 2023 $ 6,231.1 $ 1,736.5 $ 7,967.6 Accumulated impairments (3,110.3) (929.8) (4,040.1) Net balance at September 30, 2023 $ 3,120.8 $ 806.7 $ 3,927.5 Other Intangible Assets, net Other intangible assets, net as of September 30, 2023 and June 30, 2023 are presented below: September 30, June 30, Indefinite-lived other intangible assets $ 940.8 $ 950.8 Finite-lived other intangible assets, net 2,747.6 2,847.2 Total Other intangible assets, net $ 3,688.4 $ 3,798.0 The changes in the carrying amount of indefinite-lived other intangible assets are presented below: Trademarks Total Gross balance at June 30, 2023 $ 1,895.7 $ 1,895.7 Accumulated impairments (944.9) (944.9) Net balance at June 30, 2023 $ 950.8 $ 950.8 Changes during the period ended September 30, 2023 Foreign currency translation (10.0) (10.0) Gross balance at September 30, 2023 $ 1,885.7 $ 1,885.7 Accumulated impairments (944.9) (944.9) Net balance at September 30, 2023 $ 940.8 $ 940.8 Intangible assets subject to amortization are presented below: Cost Accumulated Amortization Accumulated Impairment Net June 30, 2023 License agreements and collaboration agreements $ 3,756.2 $ (1,282.6) $ (19.6) $ 2,454.0 Customer relationships 750.6 (505.9) (5.5) 239.2 Trademarks 313.0 (180.6) (0.5) 131.9 Product formulations and technology 85.6 (63.5) — 22.1 Total $ 4,905.4 $ (2,032.6) $ (25.6) $ 2,847.2 September 30, 2023 License agreements and collaboration agreements $ 3,690.5 $ (1,301.3) $ (19.6) $ 2,369.6 Customer relationships 742.2 (507.6) (5.5) 229.1 Trademarks 310.9 (182.7) (0.5) 127.7 Product formulations and technology 84.0 (62.8) — 21.2 Total $ 4,827.6 $ (2,054.4) $ (25.6) $ 2,747.6 Amortization expense was $48.6 and $47.3 for the three months ended September 30, 2023 and 2022, respectively. |
LEASES
LEASES | 3 Months Ended |
Sep. 30, 2023 | |
Leases [Abstract] | |
LEASES | LEASES The Company leases office facilities under non-cancelable operating leases with terms generally ranging between 4 and 25 years. The Company utilizes these leased office facilities for use by its employees in countries in which the Company conducts its business. Leases are negotiated with third parties and, in some instances contain renewal, expansion and termination options. The Company also subleases certain office facilities to third parties when the Company no longer intends to utilize the space. None of the Company’s leases restricts the payment of dividends or the incurrence of debt or additional lease obligations, or contain significant purchase options. The following chart provides additional information about the Company’s operating leases: Three Months Ended Lease Cost: 2023 2022 Operating lease cost $ 19.1 $ 19.2 Short-term lease cost 0.3 0.2 Variable lease cost 10.8 8.6 Sublease income (3.9) (3.8) Net lease cost $ 26.3 $ 24.2 Other information: Operating cash outflows from operating leases $ (19.2) $ (21.7) Right-of-use assets obtained in exchange for lease obligations $ 15.0 $ 7.6 Weighted-average remaining lease term - real estate 7.0 years 7.6 years Weighted-average discount rate - real estate leases 4.29 % 4.02 % Future minimum lease payments for the Company’s operating leases are as follows: Fiscal Year Ending June 30, 2024, remaining $ 55.7 2025 62.3 2026 53.9 2027 46.0 2028 33.8 Thereafter 105.7 Total future lease payments 357.4 Less: imputed interest (53.2) Total present value of lease liabilities 304.2 Current operating lease liabilities 59.9 Long-term operating lease liabilities 244.3 Total operating lease liabilities $ 304.2 Table excludes obligations for leases with original terms of twelve months or less, which have not been recognized as right-of-use assets or liabilities in the Condensed Consolidated Balance Sheets. |
DEBT
DEBT | 3 Months Ended |
Sep. 30, 2023 | |
Debt Disclosure [Abstract] | |
DEBT | DEBT The Company’s debt balances consisted of the following as of September 30, 2023 and June 30, 2023, respectively: September 30, June 30, Short-term debt $ 6.0 $ — Senior Secured Notes 2026 Dollar Senior Secured Notes due April 2026 900.0 900.0 2026 Euro Senior Secured Notes due April 2026 740.3 761.0 2028 Euro Senior Secured Notes due September 2028 528.8 — 2029 Dollar Senior Secured Notes due January 2029 500.0 500.0 2030 Dollar Senior Secured Notes due July 2030 750.0 — 2018 Coty Credit Agreement 2023 Coty Revolving Credit Facility due July 2028 85.0 — 2021 Coty Revolving Credit Facility due April 2025 — 228.9 2018 Coty Term B Facility due April 2025 — 1,183.7 Senior Unsecured Notes 2026 Dollar Notes due April 2026 473.0 473.0 2026 Euro Notes due April 2026 190.7 196.0 Brazilian Credit Facilities 31.9 31.9 Other long-term debt and finance lease obligations 6.4 7.1 Total debt 4,212.1 4,281.6 Less: Short-term debt and current portion of long-term debt (40.8) (57.9) Total Long-term debt 4,171.3 4,223.7 Less: Unamortized financing fees and discounts on long-term debt (75.9) (45.5) Total Long-term debt, net $ 4,095.4 $ 4,178.2 Short-Term Debt The Company maintains short-term lines of credit and other short-term debt with financial institutions around the world. As of September 30, 2023, total short-term debt increased by $6.0 from nil as of June 30, 2023. In addition, the Company had undrawn letters of credit of $6.8 and $7.2, and bank guarantees of $18.5 and $16.3 as of September 30, 2023 and June 30, 2023, respectively. Long-Term Debt Recent Developments Refinancing Amendment On July 11, 2023, the Company entered into an amendment to the 2018 Coty Credit Agreement that (i) refinanced all of the existing $2,000.0 of revolving credit commitments and the outstanding loans made pursuant thereto (the "2021 Coty Revolving Credit Facility") with two new tranches of senior secured revolving credit commitments, one in an aggregate principal amount of $1,670.0 available in U.S. dollars and certain other currencies and the other in an aggregate principal amount of €300.0 million available in euros, maturing in July 2028 (together, the "2023 Coty Revolving Credit Facility"), (ii) provided for a credit spread adjustment of 0.10% for all interest periods, with respect to Secured Overnight Financing Rate ("SOFR") loans, (iii) added Fitch as a relevant rating agency for purposes of the collateral release provisions and determining applicable interest rates and fees and (iv) provided that certain covenants will cease to apply during a collateral release period. Offering of Senior Secured Notes On July 26, 2023, the Company issued an aggregate principal amount of $750.0 of 6.625% senior secured notes due 2030 (“2030 Dollar Senior Secured Notes”). Coty received net proceeds of $740.6 in connection with the offering of the 2030 Dollar Senior Secured Notes. In accordance with the 2018 Coty Credit Agreement (as defined below), as amended, the net proceeds received from this offering were utilized to pay down the outstanding balance of the U.S. dollar and euro portions of the 2018 Coty Term B Facility, as defined below, by $715.5 and €22.6 million (approximately $25.1), respectively, in addition to related fees and expenses thereto. On September 19, 2023, the Company issued an aggregate principal amount of €500.0 million of 5.750% senior secured notes due 2028 ("2028 Euro Senior Secured Notes") in a private offering. Coty received net proceeds of €493.8 million in connection with the offering of the 2028 Euro Senior Secured Notes. In accordance with the 2018 Coty Credit Agreement (as defined below), as amended, the net proceeds received from this offering were utilized to pay down a portion of the borrowings outstanding under the 2023 Coty Revolving Credit Facility, without a reduction in commitment. Coty used cash on hand to pay the related fees and expenses to this offering. 2018 Term B Facility Repayment On August 3, 2023, the Company repaid €408.0 million (approximately $446.1) of the debt outstanding under the 2018 Term B Facility. Senior Secured Notes On April 21, 2021, the Company issued an aggregate principal amount of $900.0 of 5.00% senior secured notes due 2026 (the “2026 Dollar Senior Secured Notes”). Coty received gross proceeds of $900.0 in connection with the offering of the 2026 Dollar Senior Secured Notes. On June 16, 2021, the Company issued an aggregate principal amount of €700.0 million of 3.875% senior secured notes due 2026 (the “2026 Euro Senior Secured Notes”) in a private offering. Coty received gross proceeds of €700.0 million in connection with the offering of the 2026 Euro Senior Secured Notes. On November 30, 2021, the Company issued an aggregate principal amount of $500.0 of 4.75% senior secured notes due 2029 ("2029 Dollar Senior Secured Notes" and, together with the 2026 Euro Senior Secured Notes, 2028 Euro Senior Secured Notes, 2029 Dollar Senior Secured Notes and 2030 Dollar Senior Secured Notes, the “Senior Secured Notes”). Coty received gross proceeds of $500.0 in connection with the offering of the 2029 Dollar Senior Secured Notes. See the above Recent Developments section for the issuances of the 2028 Euro Senior Secured Notes and 2030 Dollar Senior Secured Notes. Coty used the gross proceeds of the offerings of the Senior Secured Notes to repay a portion of the term loans outstanding under the existing credit facilities and to pay related fees and expenses thereto. The Senior Secured Notes are senior secured obligations of Coty and are guaranteed on a senior secured basis by each of Coty’s wholly-owned domestic subsidiaries that guarantees Coty’s obligations under its existing senior secured credit facilities and are secured by first priority liens on the same collateral that secures Coty’s obligations under its existing senior secured credit facilities, as described above. The Senior Secured Notes and the guarantees are equal in right of payment with all of Coty’s and the guarantors’ respective existing and future senior indebtedness and are pari passu with all of Coty’s and the guarantors’ respective existing and future indebtedness that is secured by a first priority lien on the collateral, including the existing senior secured credit facilities, to the extent of the value of such collateral. For the 2028 Euro Senior Secured Notes and the 2030 Dollar Senior Secured Notes, the collateral security and certain covenants will be released upon the respective Senior Secured Notes achieving investment grade ratings from two out of the three ratings agencies. Optional Redemption Applicable Premium The indentures governing the Senior Secured Notes specify the Applicable Premium (as defined in the respective indentures) to be paid upon early redemption of some or all of the Senior Secured Notes prior to, and on or after, April 15, 2023 for the 2026 Euro Senior Secured Notes and 2026 Dollar Senior Secured Notes, September 15, 2025 for the 2028 Euro Senior Secured Notes, January 15, 2025 for the 2029 Dollar Senior Secured Notes and July 15, 2026 for the 2030 Dollar Senior Secured Notes (the "Early Redemption Dates"). The Applicable Premium related to the respective Senior Secured Notes on any redemption date and as calculated by the Company is the greater of: (1) 1.0% of the then outstanding principal amount of the respective Senior Secured Notes; and (2) the excess, if any, of (a) the present value at such redemption date of (i) the redemption price of such respective Senior Secured Notes that would apply if such respective notes were redeemed on the respective Early Redemption Dates, (such redemption price is expressed as a percentage of the principal amount being set forth in the table appearing in the Redemption Pricing section below), plus (ii) all remaining scheduled payments of interest due on the respective Senior Secured Notes to and including the respective Early Redemption Dates, (excluding accrued but unpaid interest, if any, to, but excluding, the redemption date), with respect to each of subclause (i) and (ii), computed using a discount rate equal to the Treasury Rate in the case of the 2026 Dollar Senior Secured Notes, 2029 Dollar Senior Secured Notes and 2030 Dollar Senior Secured Notes, or Bund Rate in the case of the 2026 Euro Senior Secured Notes and the 2028 Euro Senior Secured Notes (both Treasury Rate and Bund Rate as defined in the respective indentures) as of such redemption date plus 50 basis points; over (b) the principal amount of the respective Senior Secured Notes. Redemption Pricing At any time and from time to time prior to the Early Redemption Dates, the Company may redeem some or all of the respective notes at redemption prices equal to 100% of the respective principal amounts being redeemed plus the Applicable Premium, plus accrued and unpaid interest, if any, to, but excluding, the redemption dates. At any time on or after the Early Redemption Dates, the Company may redeem some or all of the respective notes at the redemption prices (expressed in percentage of principal amount) set forth below, plus accrued and unpaid interest, if any, to, but excluding, the redemption dates, if redeemed during the twelve-month period beginning on respective dates of each of the years indicated below: Price For the period beginning 2026 Dollar Senior Secured Notes 2026 Euro Senior Secured Notes 2028 Euro Senior Secured Notes 2029 Dollar Senior Secured Notes 2030 Dollar Senior Secured Notes Year April 15, September 15, January 15, July 15, 2024 101.250% 100.969% N/A N/A N/A 2025 100.000% 100.000% 102.875% 102.375% N/A 2026 N/A N/A 101.438% 101.188% 103.313% 2027 N/A N/A 100.000% 100.000% 101.656% 2028 and thereafter N/A N/A 100.000% 100.000% 100.000% 2018 Coty Credit Agreement On April 5, 2018, the Company entered into an amended and restated credit agreement (the "2018 Coty Credit Agreement"), which, as previously disclosed, was amended most recently in July 2023. As amended and restated through July 2023, the 2018 Coty Credit Agreement provides for (a) the incurrence by the Company of (1) a senior secured term A facility in an aggregate principal amount of (i) $1,000.0 denominated in U.S. dollars and (ii) €2,035.0 million denominated in euros (the “2018 Coty Term A Facility”) and (2) a senior secured term B facility in an aggregate principal amount of (i) $1,400.0 denominated in U.S. dollars and (ii) €850.0 million denominated in euros (the “2018 Coty Term B Facility”) and (b) the incurrence by the Company and Coty B.V., a Dutch subsidiary of the Company (the “Dutch Borrower” and, together with the Company, the “Borrowers”), of the 2023 Coty Revolving Credit Facility (together with the 2018 Coty Term A Facility and the 2018 Coty Term B Facility, the "Coty Credit Facilities"). See the above Recent Developments section for information on the revolver refinancing made in July 2023. The 2018 Coty Credit Agreement, as amended, provides that with respect to the 2023 Coty Revolving Credit Facility, up to $150.0 is available for letters of credit and up to $150.0 is available for swing line loans. The 2018 Coty Credit Agreement, as amended, also permits, subject to certain terms and conditions, the incurrence of incremental facilities thereunder in an aggregate amount of (i) $1,700.0 plus (ii) an unlimited amount if the First Lien Net Leverage Ratio (as defined in the 2018 Coty Credit Agreement, as amended), at the time of incurrence of such incremental facilities and after giving effect thereto on a pro forma basis, is less than or equal to 3.00 to 1.00. The obligations of the Company under the 2018 Coty Credit Agreement, as amended, are guaranteed by the material wholly-owned subsidiaries of the Company organized in the U.S., subject to certain exceptions (the “Guarantors”) and the obligations of the Company and the Guarantors under the 2018 Coty Credit Agreement, as amended, are secured by a perfected first priority lien (subject to permitted liens) on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions. The Dutch Borrower does not guarantee the obligations of the Company under the 2018 Coty Credit Agreement or grant any liens on its assets to secure any obligations under the 2018 Coty Credit Agreement. As previously disclosed, the Company utilized proceeds from certain transactions to pay down portions of the outstanding balances of the 2018 Coty Term A Facility and 2018 Coty Term B Facility, in accordance to the 2018 Coty Credit Agreement, as amended. No balances remain outstanding under the 2018 Coty Term A Facility or 2018 Coty Term B Facility as of September 30, 2023. See the above Recent Developments section for information on the prepayments made on the 2018 Coty Term B Facility during the three months ended September 30, 2023. Senior Unsecured Notes On April 5, 2018 the Company issued, at par, $550.0 of 6.50% senior unsecured notes due 2026 (the “2026 Dollar Notes”), €550.0 million of 4.00% senior unsecured notes due 2023 (the “2023 Euro Notes”) and €250.0 million of 4.75% senior unsecured notes due 2026 (the “2026 Euro Notes” and, together with the 2023 Euro Notes, the “Euro Notes,” and the Euro Notes together with the 2026 Dollar Notes, the “Senior Unsecured Notes”) in a private offering. The Senior Unsecured Notes are senior unsecured debt obligations of the Company and will be pari passu in right of payment with all of the Company’s existing and future senior indebtedness (including the Coty Credit Facilities). The Senior Unsecured Notes are guaranteed, jointly and severally, on a senior basis by the Guarantors. The Senior Unsecured Notes are senior unsecured obligations of the Company and are effectively junior to all existing and future secured indebtedness of the Company to the extent of the value of the collateral securing such secured indebtedness. The related guarantees are senior unsecured obligations of each Guarantor and are effectively junior to all existing and future secured indebtedness of such Guarantor to the extent of the value of the collateral securing such indebtedness. The 2026 Dollar and Euro Notes will mature on April 15, 2026. The 2026 Dollar Notes will bear interest at a rate of 6.50% per annum. The 2026 Euro Notes will bear interest at a rate of 4.75% per annum. Interest on the 2026 Dollar and Euro Notes is payable semi-annually in arrears on April 15 and October 15 of each year. The Company redeemed the 2023 Euro Notes on April 15, 2022. On December 7, 2022, the Company redeemed $77.0 of the 2026 Dollar Notes and €69.7 million (approximately $72.2) of the 2026 Euro Notes. Upon the occurrence of certain change of control triggering events with respect to a series of Senior Unsecured Notes, the Company will be required to offer to repurchase all or part of the Senior Unsecured Notes of such series at 101% of their principal amount, plus accrued and unpaid interest, if any, to, but excluding, the purchase date applicable to such Senior Unsecured Notes. The Senior Unsecured Notes contain customary covenants that place restrictions in certain circumstances on, among other things, incurrence of liens, entry into sale or leaseback transactions, sales of all or substantially all of the Company’s assets and certain merger or consolidation transactions. The Senior Unsecured Notes also provide for customary events of default. Deferred Financing Costs The Company wrote off unamortized deferred issuance fees and discounts of $5.2 and $0.0 during the three months ended September 30, 2023 and 2022, respectively, which were recorded in Other expense (income), net in the Condensed Consolidated Statement of Operations. Additionally, during the three months ended September 30, 2023 and 2022, the Company capitalized deferred issuance fees of $40.4 and $0.0, respectively. Interest The 2018 Coty Credit Agreement facilities will bear interest at rates equal to, at the Company’s option, either: (1) SOFR of the applicable qualified currency, of which the Company can elect the applicable one, two, three, six or twelve month rate, plus the applicable margin; or (2) Alternate base rate (“ABR”) plus the applicable margin. In the case of the 2023 Coty Revolving Credit Facility, the applicable margin means the lesser of a percentage per annum to be determined in accordance with the leverage-based pricing grid and the debt rating-based grid below: Pricing Tier Total Net Leverage Ratio: SOFR plus: Alternative Base Rate Margin: 1.0 Greater than or equal to 4.75:1 2.000% 1.000% 2.0 Less than 4.75:1 but greater than or equal to 4.00:1 1.750% 0.750% 3.0 Less than 4.00:1 but greater than or equal to 2.75:1 1.500% 0.500% 4.0 Less than 2.75:1 but greater than or equal to 2.00:1 1.250% 0.250% 5.0 Less than 2.00:1 but greater than or equal to 1.50:1 1.125% 0.125% 6.0 Less than 1.50:1 1.000% —% Pricing Tier Debt Ratings S&P/Moody’s: SOFR plus: Alternative Base Rate Margin: 5.0 Less than BB+/Ba1 2.000% 1.000% 4.0 BB+/Ba1 1.750% 0.750% 3.0 BBB-/Baa3 1.500% 0.500% 2.0 BBB/Baa2 1.250% 0.250% 1.0 BBB+/Baa1 or higher 1.125% 0.125% Fair Value of Debt September 30, 2023 June 30, 2023 Carrying Fair Carrying Fair Senior Secured Notes $ 3,419.1 $ 3,305.0 $ 2,161.0 $ 2,066.9 2018 Coty Credit Agreement 85.0 85.0 1,412.6 1,393.5 Senior Unsecured Notes 663.7 657.0 669.0 661.5 Brazilian Credit Facilities 31.9 32.1 31.9 32.2 The fair value of the 2023 Coty Revolving Credit Facility is equal to its carrying value, as the Company has the ability to repay the outstanding principal at par value at any time. The Company uses the market approach to value its other debt instruments. The Company obtains fair values from independent pricing services or utilizes the U.S. dollar SOFR curve to determine the fair value of these debt instruments. Based on the assumptions used to value these liabilities at fair value, these debt instruments are categorized as Level 2 in the fair value hierarchy. Debt Maturities Schedule Aggregate maturities of the Company’s long-term debt, including the current portion of long-term debt and excluding short-term debt and finance lease obligations as of September 30, 2023, are presented below: Fiscal Year Ending June 30, 2024, remaining $ 31.9 2025 — 2026 2,304.0 2027 — 2028 — Thereafter 1,863.8 Total $ 4,199.7 Covenants The 2018 Coty Credit Agreement contains affirmative and negative covenants. The negative covenants include, among other things, limitations on debt, liens, dispositions, investments, fundamental changes, restricted payments and affiliate transactions. With certain exceptions as described below, the 2018 Coty Credit Agreement, as amended, includes a financial covenant that requires us to maintain a Total Net Leverage Ratio (as defined below), equal to or less than the ratios shown below for each respective test period. Quarterly Test Period Ending Total Net Leverage Ratio (a) September 30, 2023 through April 5, 2025 4.00 to 1.00 (a) Total Net Leverage Ratio means, as of any date of determination, the ratio of: (a) (i) Total Indebtedness minus (ii) unrestricted and Cash Equivalents of the Parent Borrower and its Restricted Subsidiaries as determined in accordance with GAAP to (b) Adjusted EBITDA for the most recently ended Test Period (each of the defined terms, including Adjusted EBITDA, used within the definition of Total Net Leverage Ratio have the meanings ascribed to them within the 2018 Coty Credit Agreement, as amended). Adjusted EBITDA, as defined in the 2018 Coty Credit Agreement, as amended, includes certain add backs related to cost savings, unusual events such as COVID-19, operating expense reductions and future unrealized synergies subject to certain limits and conditions as specified in the 2018 Coty Credit Agreement, as amended. In the four fiscal quarters following the closing of any Material Acquisition (as defined in the 2018 Coty Credit Agreement, as amended), including the fiscal quarter in which such Material Acquisition occurs, the maximum Total Net Leverage Ratio shall be the lesser of (i) 5.95 to 1.00 and (ii) 1.00 higher than the otherwise applicable maximum Total Net Leverage Ratio for such quarter (as set forth in the table above). Immediately after any such four fiscal quarter period, there shall be at least two consecutive fiscal quarters during which the Company's Total Net Leverage Ratio is no greater than the maximum Total Net Leverage Ratio that would otherwise have been required in the absence of such Material Acquisition, regardless of whether any additional Material Acquisitions are consummated during such period. As of September 30, 2023, the Company was in compliance with all covenants contained within the 2018 Coty Credit Agreement, as amended. |
INTEREST EXPENSE, NET
INTEREST EXPENSE, NET | 3 Months Ended |
Sep. 30, 2023 | |
Interest Income (Expense), Net [Abstract] | |
INTEREST EXPENSE, NET | INTEREST EXPENSE, NET Interest expense, net for the three months ended September 30, 2023 and 2022, respectively, is presented below: Three Months Ended 2023 2022 Interest expense $ 66.8 $ 57.6 Foreign exchange losses, net of derivative contracts 8.2 11.9 Interest income (5.2) (3.6) Total interest expense, net $ 69.8 $ 65.9 |
EMPLOYEE BENEFIT PLANS
EMPLOYEE BENEFIT PLANS | 3 Months Ended |
Sep. 30, 2023 | |
Retirement Benefits [Abstract] | |
EMPLOYEE BENEFIT PLANS | EMPLOYEE BENEFIT PLANS The components of net periodic benefit cost for pension plans and other post-employment benefit plans recognized in the Condensed Consolidated Statements of Operations are presented below: Three Months Ended September 30, Pension Plans Other Post- U.S. International Total 2023 2022 2023 2022 2023 2022 2023 2022 Service cost — — 1.3 1.2 0.1 0.2 1.4 1.4 Interest cost 0.2 0.2 3.2 2.7 0.4 0.4 3.8 3.3 Expected return on plan assets — — (1.2) (0.9) — — (1.2) (0.9) Amortization of prior service credit — — — — (0.1) (0.1) (0.1) (0.1) Amortization of net (gain) loss (0.2) (0.7) (0.6) (0.2) (0.6) (0.5) (1.4) (1.4) Net periodic benefit cost (credit) — (0.5) 2.7 2.8 (0.2) — 2.5 2.3 |
DERIVATIVE INSTRUMENTS
DERIVATIVE INSTRUMENTS | 3 Months Ended |
Sep. 30, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
DERIVATIVE INSTRUMENTS | DERIVATIVE INSTRUMENTS Foreign Exchange Risk The Company is exposed to foreign currency exchange fluctuations through its global operations. The Company may reduce its exposure to fluctuations in the cash flows associated with changes in foreign exchange rates by creating offsetting positions through the use of derivative instruments and also by designating foreign currency denominated borrowings and cross-currency swaps as hedges of net investments in foreign subsidiaries. The Company expects that through hedging, any gain or loss on the derivative instruments would generally offset the expected increase or decrease in the value of the underlying forecasted transactions. As of September 30, 2023 and June 30, 2023, the notional amount of the outstanding forward foreign exchange contracts designated as cash flow hedges were $29.1 and $28.0, respectively. The Company also uses certain derivatives not designated as hedging instruments consisting primarily of foreign currency forward contracts and cross-currency swaps to hedge intercompany transactions and foreign currency denominated external debt. Although these derivatives were not designated for hedge accounting, the overall objective of mitigating foreign currency exposure is the same for all derivative instruments. For derivatives not designated as hedging instruments, changes in fair value are recorded in the line item in the Condensed Consolidated Statements of Operations to which the derivative relates. As of September 30, 2023 and June 30, 2023, the notional amounts of these outstanding non-designated foreign currency forward and cross-currency swap contracts were $1,465.1 and $1,653.5, respectively. Interest Rate Risk The Company is exposed to interest rate fluctuations related to its variable rate debt instruments. The Company may reduce its exposure to fluctuations in the cash flows associated with changes in the variable interest rates by entering into offsetting positions through the use of derivative instruments, such as interest rate swap contracts. The interest rate swap contracts result in recognizing a fixed interest rate for the portion of the Company’s variable rate debt that was hedged. This will reduce the negative and positive impact of increases in the variable rates over the term of the contracts. Hedge effectiveness of interest rate swap contracts is based on a long-haul hypothetical derivative methodology and includes all changes in value. As of September 30, 2023 and June 30, 2023, the Company had interest rate swap contracts designated as effective hedges in the notional amount of $200.0. These interest rate swaps are designated and qualify as cash flow hedges and were highly effective. Net Investment Hedge Foreign currency gains and losses on borrowings designated as a net investment hedge, except ineffective portions, are reported in the cumulative translation adjustment (“CTA”) component of accumulated other comprehensive income (loss) ("AOCI/(L)"), along with the foreign currency translation adjustments on those investments. As of September 30, 2023 and June 30, 2023, the nominal exposures of foreign currency denominated borrowings designated as net investment hedges were €835.9 million and €701.3 million, respectively. The designated hedge amounts were considered highly effective. Forward Repurchase Contracts In June and December 2022, the Company entered into certain forward repurchase contracts to start hedging for potential $200.0 and $196.0 share buyback programs, in 2024 and 2025, respectively. These forward repurchase contracts are accounted for at fair value, with changes in the fair value recorded in Other expense (income), net in the Condensed Consolidated Statements of Operations. Refer to Note 13—Equity and Convertible Preferred Stock. Derivative and non-derivative financial instruments which are designated as hedging instruments: The accumulated gain (loss) on foreign currency borrowings classified as net investment hedges in the foreign currency translation adjustment component of AOCI/(L) was $5.5 and $(12.2) as of September 30, 2023 and June 30, 2023, respectively. In September 2020, the Company terminated its net investment cross-currency swap derivative with a notional amount of $550.0 in exchange for cash payment of $37.6. The loss related to this termination of $(37.6) is included in AOCI/(L) as of September 30, 2023 and June 30, 2023, and will remain until the sale or substantial liquidation of the underlying net investments. The amount of gains and losses recognized in Other comprehensive income (loss) (“OCI”) in the Condensed Consolidated Balance Sheets related to the Company’s derivative and non-derivative financial instruments which are designated as hedging instruments is presented below: Gain (Loss) Recognized in OCI Three Months Ended 2023 2022 Foreign exchange forward contracts $ 1.1 $ 1.7 Interest rate swap contracts 1.0 1.7 Net investment hedges 17.7 (5.3) The accumulated (loss) gain on derivative instruments classified as cash flow hedges in AOCI/(L), net of tax, was $2.2 and $0.7 as of September 30, 2023 and June 30, 2023, respectively. The estimated net gain related to these effective hedges that is expected to be reclassified from AOCI/(L) into earnings, net of tax, within the next twelve months is $1.5. As of September 30, 2023, all of the Company's remaining foreign currency forward contracts designated as hedges were highly effective. The amount of gains and losses reclassified from AOCI/(L) to the Condensed Consolidated Statements of Operations related to the Company’s derivative financial instruments which are designated as hedging instruments is presented below: Location and Amount of Gain (Loss) Recognized in Income on Cash Flow Hedging Relationships Three Months Ended September 30, 2023 2022 Cost of sales Interest expense, net Cost of sales Interest expense, net Foreign exchange forward contracts: Amount of gain (loss) reclassified from AOCI into income $ (0.7) $ — $ (1.5) $ — Interest rate swap contracts: Amount of gain (loss) reclassified from AOCI into income — 0.6 — 1.8 Derivatives not designated as hedging: The amount of gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments is presented below: Condensed Consolidated Statements of Operations Three Months Ended 2023 2022 Foreign exchange contracts Selling, general and administrative expenses $ 0.1 $ — Foreign exchange contracts Interest expense, net (29.4) (34.2) Foreign exchange and forward repurchase contracts Other (expense) income, net (75.7) (52.0) |
EQUITY AND CONVERTIBLE PREFERRE
EQUITY AND CONVERTIBLE PREFERRED STOCK | 3 Months Ended |
Sep. 30, 2023 | |
Equity [Abstract] | |
EQUITY AND CONVERTIBLE PREFERRED STOCK | EQUITY AND CONVERTIBLE PREFERRED STOCK Common Stock As of September 30, 2023, the Company’s common stock consisted of Class A Common Stock with a par value of $0.01 per share. The holders of Class A Common Stock are entitled to one vote per share. As of September 30, 2023, total authorized shares of Class A Common Stock was 1,250.0 million and total outstanding shares of Class A Common Stock was 888.0 million. On September 28, 2023, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with a group of underwriters to issue and sell 33.0 million shares of the Company’s Class A common stock, par value $0.01 per share, at a public offering price of $10.80 (or €10.28) per share in a global offering (the “Offering”). The Company also announced the admission to listing and trading of its Common Stock on the professional segment of the Euronext Paris. 30.0 million shares were issued in euros and delivered on September 29, 2023 ("EUR shares"), and the remaining 3.0 million shares were issued in U.S. dollars and delivered on October 2, 2023 ("USD shares"). Settlement of the Offering occurred on October 2, 2023 when €299.8 million was received for the EUR shares and $31.5 was received for the USD shares, net of $10.0 of underwriting fees. Additionally, the Company incurred $5.5 in estimated other professional fees. The underwriting fees and other professional fees incurred in connection with the Offering were incremental costs directly attributable to the issuance and thus were presented as a reduction of Equity in the Condensed Consolidated Balance Sheets. The Company presented the receivables of $348.5 from the Offering as a reduction of its equity at September 30, 2023. The Company's Majority Stockholder Immediately after the Offering and taking into account the proxy agreement entered into on September 29, 2023 by and among JAB Beauty B.V. ("JAB"), Mr. Peter Harf, the Company's Chairman, and HFS Holdings S.à r.l, (“HFS”), which is beneficially owned by Mr. Harf, JAB, the Company’s largest stockholder, may be deemed to beneficially own approximately 53% of Coty’s Class A Common Stock. This is inclusive of the 3.0 million shares JAB purchased in the Offering and all voting interests of HFS, including its shares of Series B Preferred Stock on an if converted basis. The Company’s CEO, Sue Nabi, was granted a one-time sign-on award of restricted stock units on June 30, 2021. On October 29, 2021 and September 18, 2023, JAB completed the transfer of 10.0 million and 5.0 million shares of Common Stock, respectively, to Ms. Nabi pursuant to an equity transfer agreement. See Note 14—Share-Based Compensation Plans for additional information. Series A and A-1 Preferred Stock As of September 30, 2023, total authorized shares of preferred stock are 20.0 million. There are two classes of Preferred Stock, Series A Preferred Stock and Series A-1 Preferred Stock, both with a par value of $0.01 per share. As of September 30, 2023, there were 1.0 million shares of Series A and no shares of Series A-1 Preferred Stock authorized, issued and outstanding. Series A Preferred Stock and Series A-1 Preferred Stock are not entitled to receive any dividends and have no voting rights except as required by law. As of September 30, 2023, the Company has $0.2 Series A Preferred Stock classified as a liability recorded in Accrued expenses and other current liabilities in the Condensed Consolidated Balance Sheet. Convertible Series B Preferred Stock On May 11, 2020, the Company entered into an Investment Agreement with KKR Rainbow Aggregator L.P. ("KKR Aggregator"), relating to the issuance and sale by the Company to KKR Aggregator of up to 1,000,000 shares of the Company’s new Convertible Series B Preferred Stock, par value $0.01 per share (the “Series B Preferred Stock”), for an aggregate purchase price of up to $1,000.0, or $1,000 per share (the “Issuance”). The Company completed the issuances and sales of the Series B Preferred Stock on May 26, 2020 and July 31, 2020. On November 16, 2020, KKR Aggregator and affiliated investment funds agreed to sell 146,057 shares of Series B Preferred Stock, to HFS. The transaction closed on August 27, 2021. As a result of various conversions and exchanges of KKR Aggregator's shares of the Series B Preferred Stock, as of December 31, 2021, Kohlberg Kravis Roberts & Co. L.P. and its affiliates ("KKR") has fully redeemed/exchanged all of their Series B Preferred Stock. Cumulative preferred dividends accrue daily on the Series B Preferred Stock at a rate of 9.0% per year. During the three months ended September 30, 2023 and 2022, the Board of Directors declared dividends on the Series B Preferred Stock of $3.3 and paid accrued dividends of $3.3. As of September 30, 2023 and June 30, 2023, the Series B Preferred Stock had outstanding accrued dividends of $3.3. Treasury Stock Share Repurchase Program Since February 2014, the Board has authorized the Company to repurchase its Class A Common Stock under approved repurchase programs. On February 3, 2016, the Board authorized the Company to repurchase up to $500.0 of its Class A Common Stock (the “Incremental Repurchase Program”). Repurchases may be made from time to time at the Company’s discretion, based on ongoing assessments of the capital needs of the business, the market price of its Class A Common Stock, and general market conditions. For the three months ended September 30, 2023, the Company did not repurchase any shares of its Class A Common Stock under the Incremental Repurchase Program. As of September 30, 2023, the Company had authority for $396.8 remaining under the Incremental Repurchase Program. In June and December 2022, the Company entered into forward repurchase contracts (the “Forward” and together the “Forwards”) with three large financial institutions (“Counterparties”) to start hedging for potential $200.0 and $196.0 share buyback programs in 2024 and 2025, respectively. As part of the Forward agreements, the Company will pay interest on the outstanding underlying notional amount of the Forwards held by the Counterparties during the contract periods. The interest rates are variable, based on the United States secured overnight funding rate (“SOFR”) plus a spread. The weighted average interest rate plus applicable spread for the June and December 2022 Forward transactions were 9.7% and 9.7%, respectively, as of September 30, 2023. Since the Forwards permit a net cash settlement alternative in addition to the physical settlement, the Company accounted for the Forwards initially and subsequently at their fair value, with changes in the fair value recorded in Other expense (income), net in the Condensed Consolidated Statement of Operations. Dividends On April 29, 2020, the Board of Directors suspended the payment of dividends on Common Stock. No dividends on Common Stock were declared for the period ended September 30, 2023. During the period ended September 30, 2023 no dividends on Common Stock were recorded to additional paid-in capital ("APIC"). The change in dividends accrued recorded to APIC in the Condensed Consolidated Balance Sheet as of September 30, 2023 and 2022 was nil, which represent dividends no longer expected to vest as a result of forfeitures of outstanding restricted stock units (“RSUs”). In addition, the Company made payments of nil and $0.4, of which $0.1 related to employee taxes, for the previously accrued dividends on RSUs that vested during the three months ended September 30, 2023 and 2022, respectively. Total accrued dividends on unvested RSUs and phantom units included in Accrued expenses and other current liabilities are $1.0 as of September 30, 2023 and June 30, 2023. In addition, accrued dividends of $0.1 are included in Other noncurrent liabilities as of September 30, 2023 and June 30, 2023. Accumulated Other Comprehensive Income (Loss) Foreign Currency Translation Adjustments Gain on Cash Flow Hedges (Loss) gain on Net Investment Hedge Other Foreign Currency Translation Adjustments Pension and Other Post-Employment Benefit Plans (a) Total Balance—July 1, 2023 $ 0.7 $ (49.8) $ (667.9) $ 54.6 $ (662.4) Other comprehensive income (loss) before reclassifications 1.5 17.7 (132.1) (1.5) (114.4) Net amounts reclassified from AOCI/(L) — — — (0.6) (0.6) Net current-period other comprehensive income (loss) 1.5 17.7 (132.1) (2.1) (115.0) Balance—September 30, 2023 $ 2.2 $ (32.1) $ (800.0) $ 52.5 $ (777.4) (a) For the three months ended September 30, 2023, other comprehensive loss before reclassifications of $1.5 and net amounts reclassified from AOCI/(L) related to pensions and other post-employment benefit plans included amortization of prior service credits and actuarial losses of $1.5, net of tax of $0.9. Foreign Currency Translation Adjustments Loss on Cash Flow Hedges Gain (loss) on Net Investment Hedge Other Foreign Currency Translation Adjustments Pension and Other Post-Employment Benefit Plans Total Balance—July 1, 2022 $ 4.3 $ 4.1 $ (770.8) $ 44.5 $ (717.9) Other comprehensive income (loss) before reclassifications 1.3 (5.3) (258.6) (2.5) (265.1) Net amounts reclassified from AOCI/(L) (0.4) — — (0.7) (1.1) Net current-period other comprehensive income (loss) 0.9 (5.3) (258.6) (3.2) (266.2) Balance—September 30, 2022 $ 5.2 $ (1.2) $ (1,029.4) $ 41.3 $ (984.1) |
SHARE-BASED COMPENSATION PLANS
SHARE-BASED COMPENSATION PLANS | 3 Months Ended |
Sep. 30, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
SHARE-BASED COMPENSATION PLANS | SHARE-BASED COMPENSATION PLANS Share-based compensation expense is recognized on a straight-line basis over the requisite service period. Total share-based compensation is shown in the table below: Three Months Ended 2023 2022 Equity plan expense (a) $ 30.2 $ 31.4 Liability plan (income) expense (0.5) (0.3) Total share-based compensation expense $ 29.7 $ 31.1 (a) Equity plan share-based compensation expense of $30.2 and $31.4 were recorded to additional paid in capital and presented in the Condensed Consolidated Statements of Equity for the three months ended September 30, 2023 and 2022, respectively. As of September 30, 2023, the total unrecognized share-based compensation expense related to stock options, restricted stock, restricted stock units and other share awards, and performance restricted stock units ("PRSUs") is $0.5, $2.8, $142.7, and $25.3, respectively. The unrecognized share-based compensation expense related to stock options, restricted stock, restricted stock units and other share awards, and PRSUs, is expected to be recognized over a weighted-average period of 0.66, 1.72, 3.98 and 2.77 years, respectively. Restricted Stock Units and Other Share Awards The Company granted no shares of RSUs and other share awards during the three months ended September 30, 2023. The Company recognized share-based compensation expense of $29.4 and $30.7 for the three months ended September 30, 2023 and 2022, respectively, of which $21.0 and $23.5 related to Ms. Nabi's award, as described below. Performance Restricted Stock Units The Company granted 2.1 million shares of PRSUs, during the three months ended September 30, 2023. The Company recognized share-based compensation expense of $0.6 and $0.0 for the three months ended September 30, 2023 and 2022, respectively, of which $0.1 and $0.0, respectively, related to Ms. Nabi's award, as described below. Long-term Equity Program for CEO The Company’s CEO, Sue Nabi, was granted a one-time sign-on award of restricted stock units (the “Award”) on June 30, 2021. The Award vested and settled in 10.0 million shares of the Company’s Class A Common Stock, par value $0.01 per share, on each of August 31, 2021, August 31, 2022 and August 31, 2023. The Company recognized the share-based compensation expense, on a straight-line basis over the vesting period, based on the fair value on the grant date. The amount of compensation cost recognized at each vesting date must at least equal the portion of the award legally vested. In connection with this Award, on October 29, 2021 and September 18, 2023, JAB, the Company’s largest stockholder and a wholly-owned subsidiary of JAB Holding Company S.à r.l., completed the transfer of 10.0 million and 5.0 million shares of Class A Common Stock, respectively, to Ms. Nabi. On August 31, 2023 and 2022, the Company issued 5.0 million and 10.0 million shares of Class A Common Stock, respectively, to Ms. Nabi in connection with the third and second vesting of the Award. Pursuant to the term of the amended employment agreement on May 4, 2023, the Company granted Ms. Nabi a one-time award of 10,416,667 RSUs and will grant a total of 10,416,665 PRSUs in five equal tranches over the next five years. These two awards will vest periodically over the next seven years in accordance with the terms discussed below. Ms. Nabi's 10,416,667 RSUs will vest and settle in shares of the Company’s Class A Common Stock, par value $0.01 per share over five years on the following vesting schedule: (i) 15% on September 1, 2024, (ii) 15% on September 1, 2025, (iii) 20% on September 1, 2026, (iv) 20% on September 1, 2027; and (v) 30% on September 1, 2028, in each case subject to Ms. Nabi’s continued employment through the applicable vesting date. The Company will recognize approximately $109.6 of share-based compensation expense, on a straight-line basis over the vesting period, based on the fair value on the grant date, net of forfeitures. The amount of compensation cost recognized at each vesting date must at least equal the portion of the award legally vested. The first tranche of Ms. Nabi's PRSU award of 2,083,333 shares shall fully vest on September 1, 2026, subject to the achievement of three-year performance objectives determined by the Board on September 28, 2023 (the grant date) and subject to Ms. Nabi’s continued employment. The next four tranches of 2,083,333 PRSUs will be granted on or around each September 1 of 2024 through 2027, which shall vest on the third-year anniversary of the respective grant date, subject in each case to the achievement of three-year performance objectives to be determined by the Board. The Company will recognize share-based compensation expense associated with these PRSUs, on a straight-line basis over the vesting period, based on the fair value on the grant date when it is probable that the performance condition will be achieved. In the event that JAB and Ms. Nabi sell shares of Common Stock for cash in a privately negotiated transaction, subject to Board approval, the Company will grant Ms. Nabi new options to acquire shares of Common Stock (the “Reload Options”) in an amount equal to the number of shares sold by Ms. Nabi in such transaction. The Reload Options will have a strike price equal to the greater of the volume weighted average price for shares at the time of the relevant transaction and the fair market value on the date of grant. The potential expense attributed to the reload options will be recognized when the reload options are granted. Restricted Stock The Company granted no shares of restricted stock, during the three months ended September 30, 2023. The Company recognized share-based compensation expense of $0.5 and $0.5 for the three months ended September 30, 2023 and 2022, respectively. Series A Preferred Stock and Series A-1 Preferred Stock The Company granted no shares of Series A Preferred Stock or Series A-1 Preferred Stock during the three months ended September 30, 2023. The Company recognized share-based compensation income of $0.6 and $0.4 for the three months ended September 30, 2023 and 2022, respectively. Non-Qualified Stock Options The Company granted no non-qualified stock options during the three months ended September 30, 2023. The Company recognized share-based compensation (income) expense of $(0.2) and $0.3 for the three months ended September 30, 2023 and 2022, respectively. |
NET INCOME ATTRIBUTABLE TO COTY
NET INCOME ATTRIBUTABLE TO COTY INC. PER COMMON SHARE | 3 Months Ended |
Sep. 30, 2023 | |
Earnings Per Share [Abstract] | |
NET INCOME ATTRIBUTABLE TO COTY INC. PER COMMON SHARE | NET INCOME ATTRIBUTABLE TO COTY INC. PER COMMON SHARE Reconciliation between the numerators and denominators of the basic and diluted income per share (“EPS”) computations is presented below: Three Months Ended 2023 2022 Amounts attributable to Coty Inc.: Net income attributable to Coty Inc. $ 1.6 $ 128.6 Convertible Series B Preferred Stock dividends (3.3) (3.3) Net (loss) income attributable to common stockholders $ (1.7) $ 125.3 Weighted-average common shares outstanding: Weighted-average common shares outstanding—Basic 854.3 842.0 Effect of dilutive stock options and Series A Preferred Stock (a) — — Effect of restricted stock and RSUs (b) — 16.5 Effect of Convertible Series B Preferred Stock (c) — 23.7 Effect of Forward Repurchase Contracts (d) — — Weighted-average common shares outstanding—Diluted 854.3 882.2 Earnings per common share: Earnings per common share - basic $ — $ 0.15 Earnings per common share - diluted (e) — 0.15 (a) For the three months ended September 30, 2023, outstanding stock options and Series A Preferred Stock with purchase or conversion rights to purchase shares of Common Stock were excluded in the computation of diluted loss per share due to the net loss incurred during the period. For the three months ended September 30, 2022, outstanding stock options and Series A Preferred Stock with purchase or conversion rights to purchase 6.2 million shares of Common Stock were anti-dilutive and excluded from the computation of diluted EPS. (b) For the three months ended September 30, 2023, RSUs were excluded from the computation of diluted loss per share due to the net loss incurred during the period. (c) For the three months ended September 30, 2023, Convertible Series B Preferred Stock was excluded from the computation of diluted loss per share due to the net loss incurred during the period. (d) For the three months ended September 30, 2023, potential shares for the Forward Repurchase Contracts were excluded from the computation of diluted loss per share due to the net loss incurred during the period. For the three months ended September 30, 2022, 3.1 million weighted average dilutive shares for the Forward Repurchase Contracts were excluded from the computation of diluted EPS as their inclusion would have been anti-dilutive. (e) Diluted EPS is adjusted by the effect of dilutive securities, including awards under the Company's equity compensation plans, the convertible Series B Preferred Stock, and the Forward Repurchase Contracts. When calculating any potential dilutive effect of stock options, Series A Preferred Stock, restricted stock, RSUs and PRSUs, the Company uses the treasury method and the if-converted method for the Convertible Series B Preferred Stock and the Forward Repurchase Contracts. |
REDEEMABLE NONCONTROLLING INTER
REDEEMABLE NONCONTROLLING INTERESTS | 3 Months Ended |
Sep. 30, 2023 | |
Noncontrolling Interest [Abstract] | |
REDEEMABLE NONCONTROLLING INTERESTS | REDEEMABLE NONCONTROLLING INTERESTS Subsidiary in the Middle East As of September 30, 2023, the noncontrolling interest holder in the Company’s subsidiary in the Middle East had a 25% ownership share. The Company adjusts the redeemable noncontrolling interests (“RNCI”) to redemption value at the end of each reporting period with changes recognized as adjustments to APIC. The Company recognized $98.6 and $93.5 as the RNCI balances as of September 30, 2023 and June 30, 2023, respectively. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 3 Months Ended |
Sep. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | COMMITMENTS AND CONTINGENCIES Legal Matters The Company is involved, from time to time, in various litigation, administrative and other legal proceedings, including regulatory actions, incidental or related to its business, including consumer class or collective actions, personal injury (mostly involving allegations related to alleged asbestos in the Company’s talc-based cosmetic products), intellectual property, competition, compliance and advertising claims litigation and disputes, among others (collectively, “Legal Proceedings”). While the Company cannot predict any final outcomes relating thereto, management believes that the outcome of current Legal Proceedings will not have a material effect upon its business, prospects, financial condition, results of operations, cash flows or the trading price of the Company’s securities. However, management’s assessment of the Company’s current Legal Proceedings is ongoing, and could change in light of the discovery of additional facts with respect to Legal Proceedings not presently known to the Company, further legal analysis, or determinations by judges, arbitrators, juries or other finders of fact or deciders of law which are not in accord with management’s evaluation of the probable liability or outcome of such Legal Proceedings. From time to time, the Company is in discussions with regulators, including discussions initiated by the Company, about actual or potential violations of law in order to remediate or mitigate associated legal or compliance risks and liabilities or penalties. As the outcomes of such proceedings are unpredictable, the Company can give no assurance that the results of any such proceedings will not materially affect its reputation, business, prospects, financial condition, results of operations, cash flows or the trading price of its securities. Brazilian Tax Assessments The Company’s Brazilian subsidiaries receive tax assessments from local, state and federal tax authorities in Brazil from time to time. Current open tax assessments as of September 30, 2023 are: Assessment received Type of assessment Type of Tax Tax period impacted Estimated amount, including interest and penalties as of September 30, 2023 Mar-18 State sales tax credits, which the Treasury Office of the State of Goiás considers as improperly registered ICMS 2016-2017 R$0.0 million (approximately $0.0) (a) Aug-20 ICMS 2017-2019 R$674.1 million (approximately $133.9) Oct-20 Federal excise taxes, which the Treasury Office of the Brazil’s Internal Revenue Service considers as improperly calculated IPI 2016-2017 R$414.6 million (approximately $82.4) Nov-22 IPI 2018-2019 R$556.5 million (approximately $110.5) Nov-20 State sales taxes, which the Treasury Office of the State of Minas Gerais considers as improperly calculated ICMS 2016-2019 R$223.0 million (approximately $44.3) Jun-21 State sales tax, which the Treasury Office of the State of Goiás considers as improperly calculated ICMS 2016-2020 R$65.2 million (approximately $13.0) (a) During the fourth quarter of fiscal 2023, the ICMS assessment received in March 2018 had an unfavorable decision at administrative instance. The Company paid the R$1.1 million (approximately $0.2) penalty in August 2023 and the case closed. The Company does not believe the outcome of this decision will weigh on other pending cases as the case factors for other open ICMS assessments are different. The Minas Gerais State tax ICMS assessment received in November 2020 is currently at the judicial process. For the Goiás State tax ICMS assessment received in August 2020, the Company has in parallel a judicial case about an additional claim for fees over the tax incentive, for which the Company received an unfavorable ruling and has filed an appeal. In the first quarter of fiscal 2024, the Company filed a motion for clarification as a step before potentially appealing to a Brazilian higher court. All other cases are currently in the administrative process. The Company expects that cases may move from the administrative to the judicial process, although the exact timing is uncertain. For cases in the judicial process, the Company will be required to make a judicial deposit or enter into a surety bond for the disputed tax assessment, interest and penalties. The judicial process in Brazil is likely to take a number of years to conclude. The Company is seeking favorable judicial and administrative decisions on the tax enforcement actions filed by the tax authorities for these assessments. The Company believes it has meritorious defenses and it has not recognized a loss for these assessments as the Company does not believe a loss is probable. Due to the fiscal environment in Brazil, the possibility of further tax assessments related to the same or similar matters cannot be ruled out. |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 3 Months Ended |
Sep. 30, 2023 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | RELATED PARTY TRANSACTIONS Relationship with KKR On December 22, 2021, the Company entered into an agreement with Rainbow UK Bidco Limited (“KKR Bidco”) (an affiliate of funds and/or separately managed accounts advised and/or managed by KKR), related to post-closing adjustments to the purchase consideration for the Coty’s Professional and Retail Hair businesses, including the Wella, Clairol, OPI and ghd brands, (together, the “Wella Business”). In relation to this agreement, the Company recognized a gain of $6.6, in the three months ended September 30, 2023, which is reported in Other expense (income), net in the Condensed Consolidated Statements of Operations. As of September 30, 2023, the Company earned the full amount advanced from the Wella Business as part of this agreement and has recognized a receivable from Wella of $4.1 for amounts earned that have not been paid. Wella As of September 30, 2023, Coty owned 25.9% of the Wella Company as an equity investment and performs certain services to Wella. Refer to Note 6— Equity Investments. In connection with the sale of the Wella Business, the Company and Wella entered into a Transitional Services Agreement (“TSA”). Subject to the terms of this TSA, the Company will perform services for Wella in exchange for related service fees. Such services include billing and collecting from Wella customers, certain logistics and warehouse services, as well as other administrative and systems support. The Company and Wella have mutually agreed to end the contracted TSA services on January 31, 2022. The Company and Wella have also entered into other manufacturing and distribution arrangements to facilitate the Wella Business transition in the U.S. and Brazil. TSA fees and other fees earned were $1.0 and $2.3, respectively, for the three months ended September 30, 2023 and $0.8 and $2.1, respectively, for the three months ended September 30, 2022. The TSA fees are principally invoiced on a cost plus basis. The TSA fees and other fees were included in Selling, general and administrative expenses and Cost of sales, respectively, in the Company's Condensed Consolidated Statement of Operations. The Company also entered into an agreement with Wella to provide management, consulting and financial services to Wella and its direct and indirect divisions, subsidiaries, parent entities and controlled affiliates (in assisting it in the management of its business). Amounts due to the Company pursuant to this arrangement as of September 30, 2023 is $0.3. As of September 30, 2023, accounts receivable from and accounts payable to Wella of $78.4 and $7.6, respectively, were included in Prepaid expenses and other current assets and Accrued expenses and other current liabilities, respectively, in the Company's Condensed Consolidated Balance Sheets. Additionally, as of September 30, 2023, the Company has accrued $34.5 related to long-term payables due to Wella included in Other noncurrent liabilities in the Company's Condensed Consolidated Balance Sheet. In accordance with the separation agreement with Wella, Coty shall retain and be solely responsible for any amounts payable to former Coty employees transferred to Wella (“Wella employees”), who participated in the Coty Long-Term Incentive Plan. The Wella employees will continue to participate and vest on the current terms for the remaining vesting period after the separation. As such, Coty will continue to recognize the share-based compensation expense for Wella employees until the existing equity awards reach their vesting date. For the three months ended September 30, 2023 and 2022, Coty recorded $0.7 and $1.7, respectively of share-based compensation expense related to Wella employees, which was presented as part of Other expense (income), net in the Condensed Consolidated Statements of Operations. The Company has certain sublease arrangements with Wella after the sale. The Company reported sublease income from Wella of $2.1 and $2.4, respectively for the three months ended September 30, 2023 and 2022. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 3 Months Ended |
Sep. 30, 2023 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | SUBSEQUENT EVENTS Euronext Paris Public Offering On September 28, 2023, the Company entered into the Underwriting Agreement with a group of underwriters to issue and sell 33.0 million shares of the Company’s Class A common stock, par value $0.01 per share (see Note 13—Equity and Convertible Preferred Stock for additional information). The Company intends to use the proceeds of approximately $348.5, net of underwriting fees, from this offering primarily to retire the principal amount of outstanding debt. Other uses include general corporate purposes, such as strategic investments in the business, working capital and capital expenditures. Settlement of the Offering occurred on October 2, 2023. Paydown of Brazilian Credit Facility On October 5, 2023, a wholly-owned subsidiary of the Company utilized cash on hand to fully paid down the U.S. Dollar-denominated credit facility in Brazil in the amount of $31.9. |
Pay vs Performance Disclosure
Pay vs Performance Disclosure - USD ($) $ in Millions | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Pay vs Performance Disclosure | ||
Net Income (Loss) Attributable to Parent | $ 1.6 | $ 128.6 |
Insider Trading Arrangements
Insider Trading Arrangements | 3 Months Ended |
Sep. 30, 2023 | |
Trading Arrangements, by Individual | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 3 Months Ended |
Sep. 30, 2023 | |
Accounting Policies [Abstract] | |
Fiscal Period | The Company operates on a fiscal year basis with a year-end of June 30. Unless otherwise noted, any reference to a year preceded by the word “fiscal” refers to the fiscal year ended June 30 of that year. For example, references to “fiscal 2024” refer to the fiscal year ending June 30, 2024. |
Basis of Presentation | Basis of Presentation The unaudited interim Condensed Consolidated Financial Statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and include the Company’s consolidated domestic and international subsidiaries. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, these unaudited interim Condensed Consolidated Financial Statements and accompanying footnotes should be read in conjunction with the Company’s Consolidated Financial Statements as of and for the year ended June 30, 2023. In the opinion of management, all adjustments, of a normal recurring nature, considered necessary for a fair presentation have been included in the Condensed Consolidated Financial Statements. The results of operations for the three months ended September 30, 2023 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending June 30, 2024. All dollar amounts (other than per share amounts) in the following discussion are in millions of United States (“U.S.”) dollars, unless otherwise indicated. |
Restricted Cash | Restricted CashRestricted cash represents funds that are not readily available for general purpose cash needs due to contractual limitations. Restricted cash is classified as a current or long-term asset based on the timing and nature of when or how the cash is expected to be used or when the restrictions are expected to lapse.Restricted cash is included as a component of Cash, cash equivalents and restricted cash in the Condensed Consolidated Statement of Cash Flows. |
Equity Investments | Equity Investments The Company elected the fair value option to account for its investment in Rainbow JVCO LTD and subsidiaries (together, "Wella" or the “Wella Company”) to align with the Company’s strategy for this investment. The fair value is updated on a quarterly basis. The investment is classified within Level 3 in the fair value hierarchy because the Company estimates the fair value of the investment using a combination of the income approach, the market approach and private transactions, when applicable. Changes in the fair value of equity investment under the fair value option are recorded in Other expense (income), net within the Condensed Consolidated Statements of Operations (see Note 6—Equity Investments). |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the period reported. Significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, the net realizable value of inventory, the fair value of equity investments, the assessment of goodwill, other intangible assets and long-lived assets for |
Tax Information | Tax Information The effective income tax rate for the three months ended September 30, 2023 and 2022 was 80.0% and 34.1%, respectively. The change in the effective tax rate for the three months ended September 30, 2023, as compared with the three months ended September 30, 2022, was primarily due to an expense of $24.3 in the current period recognized on the revaluation of the Company's deferred tax liabilities due to a tax rate increase enacted in Switzerland. The effective income tax rates vary from the U.S. federal statutory rate of 21% due to the effect of (i) jurisdictions with different statutory rates, including impacts of rate changes, (ii) adjustments to the Company’s unrealized tax benefits (“UTBs”) and accrued interest, (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements No new accounting pronouncements issued but not yet adopted are expected to have a material impact on the Company's unaudited Condensed Consolidated Financial Statements. |
Derivative Instruments | Foreign Exchange Risk The Company is exposed to foreign currency exchange fluctuations through its global operations. The Company may reduce its exposure to fluctuations in the cash flows associated with changes in foreign exchange rates by creating offsetting positions through the use of derivative instruments and also by designating foreign currency denominated borrowings and cross-currency swaps as hedges of net investments in foreign subsidiaries. The Company expects that through hedging, any gain or loss on the derivative instruments would generally offset the expected increase or decrease in the value of the underlying forecasted transactions. |
SEGMENT REPORTING (Tables)
SEGMENT REPORTING (Tables) | 3 Months Ended |
Sep. 30, 2023 | |
Segment Reporting [Abstract] | |
Schedule of reportable segments | Three Months Ended SEGMENT DATA 2023 2022 Net revenues: Prestige $ 1,064.7 $ 863.4 Consumer Beauty 576.7 526.6 Total $ 1,641.4 $ 1,390.0 Operating income (loss): Prestige 221.6 170.3 Consumer Beauty 32.0 32.0 Corporate (56.1) (30.4) Total $ 197.5 $ 171.9 Reconciliation: Operating income 197.5 171.9 Interest expense, net 69.8 65.9 Other expense (income), net 76.6 (98.2) Income before income taxes $ 51.1 $ 204.2 |
Schedule of percentage of revenues associated with product categories | Presented below are the percentage of revenues associated with the Company’s product categories: Three Months Ended PRODUCT CATEGORY 2023 2022 Fragrance 63.3 % 59.3 % Color Cosmetics 24.6 27.7 Body Care, Skin & Other 12.1 13.0 Total 100.0 % 100.0 % |
RESTRUCTURING COSTS (Tables)
RESTRUCTURING COSTS (Tables) | 3 Months Ended |
Sep. 30, 2023 | |
Restructuring and Related Activities [Abstract] | |
Schedule of restructuring costs | Restructuring costs for the three months ended September 30, 2023 and 2022 are presented below: Three Months Ended 2023 2022 2024 Restructuring Actions $ 28.6 $ — Transformation Plan and Other (0.2) (1.2) Total $ 28.4 $ (1.2) |
INVENTORIES (Tables)
INVENTORIES (Tables) | 3 Months Ended |
Sep. 30, 2023 | |
Inventory Disclosure [Abstract] | |
Schedule of inventory | Inventories as of September 30, 2023 and June 30, 2023 are presented below: September 30, June 30, Raw materials $ 215.5 $ 224.1 Work-in-process 13.9 15.6 Finished goods 616.0 613.7 Total inventories $ 845.4 $ 853.4 |
EQUITY INVESTMENTS (Tables)
EQUITY INVESTMENTS (Tables) | 3 Months Ended |
Sep. 30, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of equity investments | The Company's equity investments, classified as Equity investments in the Condensed Consolidated Balance Sheets are represented by the following: September 30, June 30, Equity method investments: KKW Holdings (a) $ 8.1 $ 8.9 Equity investments at fair value: Wella (b) 1,064.0 1,060.0 Total equity investments $ 1,072.1 $ 1,068.9 (a) On January 4, 2021, the Company completed its purchase of 20% of the outstanding equity of KKW Holdings. The Company accounts for this minority investment under the equity method, given it has the ability to exercise significant influence over, but not control, the investee. The carrying value of the Company’s investment includes basis differences allocated to amortizable intangible assets. The Company recognized $0.8 and $0.9, respectively, during the three months ended September 30, 2023 and 2022 representing its share of the investee’s net loss in Other expense (income), net within the Condensed Consolidated Statements of Operations. (b) As of September 30, 2023 and June 30, 2023, the Company's stake in Wella was 25.9%. The following table presents summarized financial information of the Company’s equity method investees for the period ending September 30, 2023. Amounts presented represent combined totals at the investee level and not the Company’s proportionate share: Three Months Ended 2023 2022 Summarized Statements of Operations information: Net revenues $ 637.3 $ 596.6 Gross profit 426.8 394.6 Operating income 44.9 61.0 (Loss) income before income taxes (6.8) 20.0 Net (loss) income (16.7) 16.0 |
Schedule of movement in equity investments | The following table summarizes movements in equity investments with fair value option that are classified within Level 3 for the period ended September 30, 2023. There were no internal movements to or from Level 3 and Level 1 or Level 2 for the period ended September 30, 2023. Equity investments at fair value: Balance as of June 30, 2023 $ 1,060.0 Total gains included in earnings 4.0 Balance as of September 30, 2023 $ 1,064.0 |
Schedule of significant unobservable inputs used in Level 3 valuation | The following table summarizes the significant unobservable inputs used in Level 3 valuation of the Company's investments carried at fair value as of September 30, 2023. Included in the table are the inputs or range of possible inputs that have an effect on the overall valuation of the financial instruments. Fair value Valuation technique Unobservable Range Equity investments at fair value $ 1,064.0 Discounted cash flows Discount rate 10.50% (a) Growth rate 1.8% - 9.2% (a) Market multiple Revenue multiple 2.1x – 2.3x (b) EBITDA multiple 10.4x – 13.9x (b) (a) The primary unobservable inputs used in the fair value measurement of the Company's equity investments with fair value option, when using a discounted cash flow method, are the discount rate and revenue growth rate. Significant increases (decreases) in the discount rate in isolation would result in a significantly lower (higher) fair value measurement. The Company estimates the discount rate based on the investees' projected cost of equity and debt. The revenue growth rate is forecasted for future years by the investee based on their best estimates. Significant increases (decreases) in the revenue growth rate in isolation would result in a significantly higher (lower) fair value measurement. (b) The primary unobservable inputs used in the fair value measurement of the Company's equity investments with fair value option, when using a market multiple method, are the revenue multiple and EBITDA multiple. Significant increases (decreases) in the revenue multiple or EBITDA multiple in isolation would result in a significantly higher (lower) fair value measurement. The market multiples are derived from a group of guideline public companies. |
GOODWILL AND OTHER INTANGIBLE_2
GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables) | 3 Months Ended |
Sep. 30, 2023 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of goodwill | Goodwill as of September 30, 2023 and June 30, 2023 is presented below: Prestige Consumer Beauty Total Gross balance at June 30, 2023 $ 6,279.2 $ 1,748.8 $ 8,028.0 Accumulated impairments (3,110.3) (929.8) (4,040.1) Net balance at June 30, 2023 $ 3,168.9 $ 819.0 $ 3,987.9 Changes during the period ended September 30, 2023 Foreign currency translation (48.1) (12.3) (60.4) Gross balance at September 30, 2023 $ 6,231.1 $ 1,736.5 $ 7,967.6 Accumulated impairments (3,110.3) (929.8) (4,040.1) Net balance at September 30, 2023 $ 3,120.8 $ 806.7 $ 3,927.5 |
Schedule of indefinite-lived intangible assets | Other intangible assets, net as of September 30, 2023 and June 30, 2023 are presented below: September 30, June 30, Indefinite-lived other intangible assets $ 940.8 $ 950.8 Finite-lived other intangible assets, net 2,747.6 2,847.2 Total Other intangible assets, net $ 3,688.4 $ 3,798.0 The changes in the carrying amount of indefinite-lived other intangible assets are presented below: Trademarks Total Gross balance at June 30, 2023 $ 1,895.7 $ 1,895.7 Accumulated impairments (944.9) (944.9) Net balance at June 30, 2023 $ 950.8 $ 950.8 Changes during the period ended September 30, 2023 Foreign currency translation (10.0) (10.0) Gross balance at September 30, 2023 $ 1,885.7 $ 1,885.7 Accumulated impairments (944.9) (944.9) Net balance at September 30, 2023 $ 940.8 $ 940.8 |
Schedule of finite-lived intangible assets | Other intangible assets, net as of September 30, 2023 and June 30, 2023 are presented below: September 30, June 30, Indefinite-lived other intangible assets $ 940.8 $ 950.8 Finite-lived other intangible assets, net 2,747.6 2,847.2 Total Other intangible assets, net $ 3,688.4 $ 3,798.0 Intangible assets subject to amortization are presented below: Cost Accumulated Amortization Accumulated Impairment Net June 30, 2023 License agreements and collaboration agreements $ 3,756.2 $ (1,282.6) $ (19.6) $ 2,454.0 Customer relationships 750.6 (505.9) (5.5) 239.2 Trademarks 313.0 (180.6) (0.5) 131.9 Product formulations and technology 85.6 (63.5) — 22.1 Total $ 4,905.4 $ (2,032.6) $ (25.6) $ 2,847.2 September 30, 2023 License agreements and collaboration agreements $ 3,690.5 $ (1,301.3) $ (19.6) $ 2,369.6 Customer relationships 742.2 (507.6) (5.5) 229.1 Trademarks 310.9 (182.7) (0.5) 127.7 Product formulations and technology 84.0 (62.8) — 21.2 Total $ 4,827.6 $ (2,054.4) $ (25.6) $ 2,747.6 |
LEASES (Tables)
LEASES (Tables) | 3 Months Ended |
Sep. 30, 2023 | |
Leases [Abstract] | |
Schedule of lease cost | The following chart provides additional information about the Company’s operating leases: Three Months Ended Lease Cost: 2023 2022 Operating lease cost $ 19.1 $ 19.2 Short-term lease cost 0.3 0.2 Variable lease cost 10.8 8.6 Sublease income (3.9) (3.8) Net lease cost $ 26.3 $ 24.2 Other information: Operating cash outflows from operating leases $ (19.2) $ (21.7) Right-of-use assets obtained in exchange for lease obligations $ 15.0 $ 7.6 Weighted-average remaining lease term - real estate 7.0 years 7.6 years Weighted-average discount rate - real estate leases 4.29 % 4.02 % |
Schedule of future minimum lease payments for operating leases | Future minimum lease payments for the Company’s operating leases are as follows: Fiscal Year Ending June 30, 2024, remaining $ 55.7 2025 62.3 2026 53.9 2027 46.0 2028 33.8 Thereafter 105.7 Total future lease payments 357.4 Less: imputed interest (53.2) Total present value of lease liabilities 304.2 Current operating lease liabilities 59.9 Long-term operating lease liabilities 244.3 Total operating lease liabilities $ 304.2 Table excludes obligations for leases with original terms of twelve months or less, which have not been recognized as right-of-use assets or liabilities in the Condensed Consolidated Balance Sheets. |
DEBT (Tables)
DEBT (Tables) | 3 Months Ended |
Sep. 30, 2023 | |
Debt Disclosure [Abstract] | |
Schedule of debt | The Company’s debt balances consisted of the following as of September 30, 2023 and June 30, 2023, respectively: September 30, June 30, Short-term debt $ 6.0 $ — Senior Secured Notes 2026 Dollar Senior Secured Notes due April 2026 900.0 900.0 2026 Euro Senior Secured Notes due April 2026 740.3 761.0 2028 Euro Senior Secured Notes due September 2028 528.8 — 2029 Dollar Senior Secured Notes due January 2029 500.0 500.0 2030 Dollar Senior Secured Notes due July 2030 750.0 — 2018 Coty Credit Agreement 2023 Coty Revolving Credit Facility due July 2028 85.0 — 2021 Coty Revolving Credit Facility due April 2025 — 228.9 2018 Coty Term B Facility due April 2025 — 1,183.7 Senior Unsecured Notes 2026 Dollar Notes due April 2026 473.0 473.0 2026 Euro Notes due April 2026 190.7 196.0 Brazilian Credit Facilities 31.9 31.9 Other long-term debt and finance lease obligations 6.4 7.1 Total debt 4,212.1 4,281.6 Less: Short-term debt and current portion of long-term debt (40.8) (57.9) Total Long-term debt 4,171.3 4,223.7 Less: Unamortized financing fees and discounts on long-term debt (75.9) (45.5) Total Long-term debt, net $ 4,095.4 $ 4,178.2 |
Schedule of debt instrument redemption | At any time on or after the Early Redemption Dates, the Company may redeem some or all of the respective notes at the redemption prices (expressed in percentage of principal amount) set forth below, plus accrued and unpaid interest, if any, to, but excluding, the redemption dates, if redeemed during the twelve-month period beginning on respective dates of each of the years indicated below: Price For the period beginning 2026 Dollar Senior Secured Notes 2026 Euro Senior Secured Notes 2028 Euro Senior Secured Notes 2029 Dollar Senior Secured Notes 2030 Dollar Senior Secured Notes Year April 15, September 15, January 15, July 15, 2024 101.250% 100.969% N/A N/A N/A 2025 100.000% 100.000% 102.875% 102.375% N/A 2026 N/A N/A 101.438% 101.188% 103.313% 2027 N/A N/A 100.000% 100.000% 101.656% 2028 and thereafter N/A N/A 100.000% 100.000% 100.000% |
Schedule of total net leverage ratio requirement | In the case of the 2023 Coty Revolving Credit Facility, the applicable margin means the lesser of a percentage per annum to be determined in accordance with the leverage-based pricing grid and the debt rating-based grid below: Pricing Tier Total Net Leverage Ratio: SOFR plus: Alternative Base Rate Margin: 1.0 Greater than or equal to 4.75:1 2.000% 1.000% 2.0 Less than 4.75:1 but greater than or equal to 4.00:1 1.750% 0.750% 3.0 Less than 4.00:1 but greater than or equal to 2.75:1 1.500% 0.500% 4.0 Less than 2.75:1 but greater than or equal to 2.00:1 1.250% 0.250% 5.0 Less than 2.00:1 but greater than or equal to 1.50:1 1.125% 0.125% 6.0 Less than 1.50:1 1.000% —% Pricing Tier Debt Ratings S&P/Moody’s: SOFR plus: Alternative Base Rate Margin: 5.0 Less than BB+/Ba1 2.000% 1.000% 4.0 BB+/Ba1 1.750% 0.750% 3.0 BBB-/Baa3 1.500% 0.500% 2.0 BBB/Baa2 1.250% 0.250% 1.0 BBB+/Baa1 or higher 1.125% 0.125% transactions. With certain exceptions as described below, the 2018 Coty Credit Agreement, as amended, includes a financial covenant that requires us to maintain a Total Net Leverage Ratio (as defined below), equal to or less than the ratios shown below for each respective test period. Quarterly Test Period Ending Total Net Leverage Ratio (a) September 30, 2023 through April 5, 2025 4.00 to 1.00 (a) Total Net Leverage Ratio means, as of any date of determination, the ratio of: (a) (i) Total Indebtedness minus (ii) unrestricted and Cash Equivalents of the Parent Borrower and its Restricted Subsidiaries as determined in accordance with GAAP to (b) Adjusted EBITDA for the most recently ended Test Period (each of the defined terms, including Adjusted EBITDA, used within the definition of Total Net Leverage Ratio have the meanings ascribed to them within the 2018 Coty Credit Agreement, as amended). Adjusted EBITDA, as defined in the 2018 Coty Credit Agreement, as amended, includes certain add backs related to cost savings, unusual events such as COVID-19, operating expense reductions and future unrealized synergies subject to certain limits and conditions as specified in the 2018 Coty Credit Agreement, as amended. |
Schedule of line of credit facilities | Fair Value of Debt September 30, 2023 June 30, 2023 Carrying Fair Carrying Fair Senior Secured Notes $ 3,419.1 $ 3,305.0 $ 2,161.0 $ 2,066.9 2018 Coty Credit Agreement 85.0 85.0 1,412.6 1,393.5 Senior Unsecured Notes 663.7 657.0 669.0 661.5 Brazilian Credit Facilities 31.9 32.1 31.9 32.2 |
Schedule of maturities of long-term debt | Aggregate maturities of the Company’s long-term debt, including the current portion of long-term debt and excluding short-term debt and finance lease obligations as of September 30, 2023, are presented below: Fiscal Year Ending June 30, 2024, remaining $ 31.9 2025 — 2026 2,304.0 2027 — 2028 — Thereafter 1,863.8 Total $ 4,199.7 |
INTEREST EXPENSE, NET (Tables)
INTEREST EXPENSE, NET (Tables) | 3 Months Ended |
Sep. 30, 2023 | |
Interest Income (Expense), Net [Abstract] | |
Schedule of interest expense, net | Interest expense, net for the three months ended September 30, 2023 and 2022, respectively, is presented below: Three Months Ended 2023 2022 Interest expense $ 66.8 $ 57.6 Foreign exchange losses, net of derivative contracts 8.2 11.9 Interest income (5.2) (3.6) Total interest expense, net $ 69.8 $ 65.9 |
EMPLOYEE BENEFIT PLANS (Tables)
EMPLOYEE BENEFIT PLANS (Tables) | 3 Months Ended |
Sep. 30, 2023 | |
Retirement Benefits [Abstract] | |
Schedule of net benefit costs | The components of net periodic benefit cost for pension plans and other post-employment benefit plans recognized in the Condensed Consolidated Statements of Operations are presented below: Three Months Ended September 30, Pension Plans Other Post- U.S. International Total 2023 2022 2023 2022 2023 2022 2023 2022 Service cost — — 1.3 1.2 0.1 0.2 1.4 1.4 Interest cost 0.2 0.2 3.2 2.7 0.4 0.4 3.8 3.3 Expected return on plan assets — — (1.2) (0.9) — — (1.2) (0.9) Amortization of prior service credit — — — — (0.1) (0.1) (0.1) (0.1) Amortization of net (gain) loss (0.2) (0.7) (0.6) (0.2) (0.6) (0.5) (1.4) (1.4) Net periodic benefit cost (credit) — (0.5) 2.7 2.8 (0.2) — 2.5 2.3 |
DERIVATIVE INSTRUMENTS (Tables)
DERIVATIVE INSTRUMENTS (Tables) | 3 Months Ended |
Sep. 30, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of amount of gains and losses recognized in Other comprehensive income (loss) | The amount of gains and losses recognized in Other comprehensive income (loss) (“OCI”) in the Condensed Consolidated Balance Sheets related to the Company’s derivative and non-derivative financial instruments which are designated as hedging instruments is presented below: Gain (Loss) Recognized in OCI Three Months Ended 2023 2022 Foreign exchange forward contracts $ 1.1 $ 1.7 Interest rate swap contracts 1.0 1.7 Net investment hedges 17.7 (5.3) |
Schedule of amount of gains and losses recognized in other comprehensive income (loss) | The amount of gains and losses recognized in Other comprehensive income (loss) (“OCI”) in the Condensed Consolidated Balance Sheets related to the Company’s derivative and non-derivative financial instruments which are designated as hedging instruments is presented below: Gain (Loss) Recognized in OCI Three Months Ended 2023 2022 Foreign exchange forward contracts $ 1.1 $ 1.7 Interest rate swap contracts 1.0 1.7 Net investment hedges 17.7 (5.3) |
Schedule of amount of gains and losses reclassified from AOCI(L) | The amount of gains and losses reclassified from AOCI/(L) to the Condensed Consolidated Statements of Operations related to the Company’s derivative financial instruments which are designated as hedging instruments is presented below: Location and Amount of Gain (Loss) Recognized in Income on Cash Flow Hedging Relationships Three Months Ended September 30, 2023 2022 Cost of sales Interest expense, net Cost of sales Interest expense, net Foreign exchange forward contracts: Amount of gain (loss) reclassified from AOCI into income $ (0.7) $ — $ (1.5) $ — Interest rate swap contracts: Amount of gain (loss) reclassified from AOCI into income — 0.6 — 1.8 |
Schedule of derivatives not designated as hedging | The amount of gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments is presented below: Condensed Consolidated Statements of Operations Three Months Ended 2023 2022 Foreign exchange contracts Selling, general and administrative expenses $ 0.1 $ — Foreign exchange contracts Interest expense, net (29.4) (34.2) Foreign exchange and forward repurchase contracts Other (expense) income, net (75.7) (52.0) |
EQUITY AND CONVERTIBLE PREFER_2
EQUITY AND CONVERTIBLE PREFERRED STOCK (Tables) | 3 Months Ended |
Sep. 30, 2023 | |
Equity [Abstract] | |
Schedule of accumulated other comprehensive income (loss) | Accumulated Other Comprehensive Income (Loss) Foreign Currency Translation Adjustments Gain on Cash Flow Hedges (Loss) gain on Net Investment Hedge Other Foreign Currency Translation Adjustments Pension and Other Post-Employment Benefit Plans (a) Total Balance—July 1, 2023 $ 0.7 $ (49.8) $ (667.9) $ 54.6 $ (662.4) Other comprehensive income (loss) before reclassifications 1.5 17.7 (132.1) (1.5) (114.4) Net amounts reclassified from AOCI/(L) — — — (0.6) (0.6) Net current-period other comprehensive income (loss) 1.5 17.7 (132.1) (2.1) (115.0) Balance—September 30, 2023 $ 2.2 $ (32.1) $ (800.0) $ 52.5 $ (777.4) (a) For the three months ended September 30, 2023, other comprehensive loss before reclassifications of $1.5 and net amounts reclassified from AOCI/(L) related to pensions and other post-employment benefit plans included amortization of prior service credits and actuarial losses of $1.5, net of tax of $0.9. Foreign Currency Translation Adjustments Loss on Cash Flow Hedges Gain (loss) on Net Investment Hedge Other Foreign Currency Translation Adjustments Pension and Other Post-Employment Benefit Plans Total Balance—July 1, 2022 $ 4.3 $ 4.1 $ (770.8) $ 44.5 $ (717.9) Other comprehensive income (loss) before reclassifications 1.3 (5.3) (258.6) (2.5) (265.1) Net amounts reclassified from AOCI/(L) (0.4) — — (0.7) (1.1) Net current-period other comprehensive income (loss) 0.9 (5.3) (258.6) (3.2) (266.2) Balance—September 30, 2022 $ 5.2 $ (1.2) $ (1,029.4) $ 41.3 $ (984.1) |
SHARE-BASED COMPENSATION PLANS
SHARE-BASED COMPENSATION PLANS (Tables) | 3 Months Ended |
Sep. 30, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Schedule of share-based compensation expense | Share-based compensation expense is recognized on a straight-line basis over the requisite service period. Total share-based compensation is shown in the table below: Three Months Ended 2023 2022 Equity plan expense (a) $ 30.2 $ 31.4 Liability plan (income) expense (0.5) (0.3) Total share-based compensation expense $ 29.7 $ 31.1 (a) Equity plan share-based compensation expense of $30.2 and $31.4 were recorded to additional paid in capital and presented in the Condensed Consolidated Statements of Equity for the three months ended September 30, 2023 and 2022, respectively. |
NET INCOME ATTRIBUTABLE TO CO_2
NET INCOME ATTRIBUTABLE TO COTY INC. PER COMMON SHARE (Tables) | 3 Months Ended |
Sep. 30, 2023 | |
Earnings Per Share [Abstract] | |
Schedule of reconciliation of numerators and denominators of basic and diluted EPS computations | Reconciliation between the numerators and denominators of the basic and diluted income per share (“EPS”) computations is presented below: Three Months Ended 2023 2022 Amounts attributable to Coty Inc.: Net income attributable to Coty Inc. $ 1.6 $ 128.6 Convertible Series B Preferred Stock dividends (3.3) (3.3) Net (loss) income attributable to common stockholders $ (1.7) $ 125.3 Weighted-average common shares outstanding: Weighted-average common shares outstanding—Basic 854.3 842.0 Effect of dilutive stock options and Series A Preferred Stock (a) — — Effect of restricted stock and RSUs (b) — 16.5 Effect of Convertible Series B Preferred Stock (c) — 23.7 Effect of Forward Repurchase Contracts (d) — — Weighted-average common shares outstanding—Diluted 854.3 882.2 Earnings per common share: Earnings per common share - basic $ — $ 0.15 Earnings per common share - diluted (e) — 0.15 (a) For the three months ended September 30, 2023, outstanding stock options and Series A Preferred Stock with purchase or conversion rights to purchase shares of Common Stock were excluded in the computation of diluted loss per share due to the net loss incurred during the period. For the three months ended September 30, 2022, outstanding stock options and Series A Preferred Stock with purchase or conversion rights to purchase 6.2 million shares of Common Stock were anti-dilutive and excluded from the computation of diluted EPS. (b) For the three months ended September 30, 2023, RSUs were excluded from the computation of diluted loss per share due to the net loss incurred during the period. (c) For the three months ended September 30, 2023, Convertible Series B Preferred Stock was excluded from the computation of diluted loss per share due to the net loss incurred during the period. (d) For the three months ended September 30, 2023, potential shares for the Forward Repurchase Contracts were excluded from the computation of diluted loss per share due to the net loss incurred during the period. For the three months ended September 30, 2022, 3.1 million weighted average dilutive shares for the Forward Repurchase Contracts were excluded from the computation of diluted EPS as their inclusion would have been anti-dilutive. (e) Diluted EPS is adjusted by the effect of dilutive securities, including awards under the Company's equity compensation plans, the convertible Series B Preferred Stock, and the Forward Repurchase Contracts. When calculating any potential dilutive effect of stock options, Series A Preferred Stock, restricted stock, RSUs and PRSUs, the Company uses the treasury method and the if-converted method for the Convertible Series B Preferred Stock and the Forward Repurchase Contracts. |
COMMITMENT AND CONTINGENCIES (T
COMMITMENT AND CONTINGENCIES (Tables) | 3 Months Ended |
Sep. 30, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Schedule of income tax contingencies | The Company’s Brazilian subsidiaries receive tax assessments from local, state and federal tax authorities in Brazil from time to time. Current open tax assessments as of September 30, 2023 are: Assessment received Type of assessment Type of Tax Tax period impacted Estimated amount, including interest and penalties as of September 30, 2023 Mar-18 State sales tax credits, which the Treasury Office of the State of Goiás considers as improperly registered ICMS 2016-2017 R$0.0 million (approximately $0.0) (a) Aug-20 ICMS 2017-2019 R$674.1 million (approximately $133.9) Oct-20 Federal excise taxes, which the Treasury Office of the Brazil’s Internal Revenue Service considers as improperly calculated IPI 2016-2017 R$414.6 million (approximately $82.4) Nov-22 IPI 2018-2019 R$556.5 million (approximately $110.5) Nov-20 State sales taxes, which the Treasury Office of the State of Minas Gerais considers as improperly calculated ICMS 2016-2019 R$223.0 million (approximately $44.3) Jun-21 State sales tax, which the Treasury Office of the State of Goiás considers as improperly calculated ICMS 2016-2020 R$65.2 million (approximately $13.0) (a) During the fourth quarter of fiscal 2023, the ICMS assessment received in March 2018 had an unfavorable decision at administrative instance. The Company paid the R$1.1 million (approximately $0.2) penalty in August 2023 and the case closed. The Company does not believe the outcome of this decision will weigh on other pending cases as the case factors for other open ICMS assessments are different. |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Jun. 30, 2023 | |
Significant Accounting Policies [Line Items] | |||
Restricted cash | $ 37.7 | $ 36.9 | |
Effective income tax rate, percentage | 80% | 34.10% | |
Change in enacted tax rate, amount | $ 24.3 | ||
Gross unrecognized tax benefits | $ 233.1 | 235.5 | |
Unrecognized tax benefits that would impact effective tax rate | 183.8 | ||
Unrecognized tax benefits, net | 218.8 | 218.6 | |
Interest and penalties expense | 1.3 | 1.3 | |
Gross accrued interest and penalties | 34.4 | $ 33.1 | |
Reasonably possible decrease in UTBs (up to) | 11.3 | ||
Russia Market Exit | |||
Significant Accounting Policies [Line Items] | |||
Pre-tax losses on net deferred income tax (liability) asset | $ (0.1) | $ (1.1) |
SEGMENT REPORTING - Reporting S
SEGMENT REPORTING - Reporting Segments (Details) - USD ($) $ in Millions | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Segment Reporting Information [Line Items] | ||
Net revenues | $ 1,641.4 | $ 1,390 |
Operating income (loss) | 197.5 | 171.9 |
Interest expense, net | 69.8 | 65.9 |
Other expense (income), net | 76.6 | (98.2) |
Income before income taxes | 51.1 | 204.2 |
Operating Segments | Prestige | ||
Segment Reporting Information [Line Items] | ||
Net revenues | 1,064.7 | 863.4 |
Operating income (loss) | 221.6 | 170.3 |
Operating Segments | Consumer Beauty | ||
Segment Reporting Information [Line Items] | ||
Net revenues | 576.7 | 526.6 |
Operating income (loss) | 32 | 32 |
Operating Segments | Corporate | ||
Segment Reporting Information [Line Items] | ||
Operating income (loss) | $ (56.1) | $ (30.4) |
SEGMENT REPORTING - Reportable
SEGMENT REPORTING - Reportable Segments, Revenue by Product Category (Details) - Product Concentration Risk - Sales Revenue | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Segment Reporting Information [Line Items] | ||
Percentage of consolidated revenues | 100% | 100% |
Fragrance | ||
Segment Reporting Information [Line Items] | ||
Percentage of consolidated revenues | 63.30% | 59.30% |
Color Cosmetics | ||
Segment Reporting Information [Line Items] | ||
Percentage of consolidated revenues | 24.60% | 27.70% |
Body Care, Skin & Other | ||
Segment Reporting Information [Line Items] | ||
Percentage of consolidated revenues | 12.10% | 13% |
RESTRUCTURING COSTS - Restructu
RESTRUCTURING COSTS - Restructuring Costs by Program (Details) - USD ($) $ in Millions | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Restructuring Cost and Reserve [Line Items] | ||
Restructuring costs | $ 28.4 | $ (1.2) |
2024 Restructuring Actions | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring costs | 28.6 | 0 |
Transformation Plan and Other | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring costs | $ (0.2) | $ (1.2) |
RESTRUCTURING COSTS - Narrative
RESTRUCTURING COSTS - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||
Sep. 30, 2023 | Sep. 30, 2022 | Jun. 30, 2024 | Jun. 30, 2026 | Jun. 30, 2025 | Jun. 30, 2023 | |
Restructuring Cost and Reserve [Line Items] | ||||||
Restructuring expense (income) | $ 28.4 | $ (1.2) | ||||
2024 Restructuring Actions | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Expected restructuring and related costs | 30 | |||||
Restructuring costs incurred to date | 29.9 | |||||
Restructuring expense (income) | 28.6 | 0 | ||||
Restructuring reserve | 29.9 | $ 0 | ||||
2024 Restructuring Actions | Forecast | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Payments for restructuring | $ 6.8 | $ 13.8 | $ 9.3 | |||
Transformation Plan and Other | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Restructuring costs incurred to date | 215.3 | |||||
Restructuring expense (income) | (0.2) | $ (1.2) | ||||
Restructuring reserve | $ 7.5 | $ 10 | ||||
Restructuring and related activities, plan term (in years) | 4 years | |||||
Transformation Plan and Other | Forecast | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Payments for restructuring | $ 6.1 | $ 0.1 | $ 1.3 |
INVENTORIES (Details)
INVENTORIES (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Jun. 30, 2023 |
Inventory Disclosure [Abstract] | ||
Raw materials | $ 215.5 | $ 224.1 |
Work-in-process | 13.9 | 15.6 |
Finished goods | 616 | 613.7 |
Total inventories | $ 845.4 | $ 853.4 |
EQUITY INVESTMENTS - Schedule o
EQUITY INVESTMENTS - Schedule of Equity Investments (Details) - USD ($) $ in Millions | 3 Months Ended | |||
Sep. 30, 2023 | Sep. 30, 2022 | Jun. 30, 2023 | Jan. 04, 2021 | |
Debt and Equity Securities, FV-NI [Line Items] | ||||
Total equity investments | $ 1,072.1 | $ 1,068.9 | ||
KKW Beauty | ||||
Debt and Equity Securities, FV-NI [Line Items] | ||||
Percentage of equity interests acquired | 20% | |||
KKW Beauty | ||||
Debt and Equity Securities, FV-NI [Line Items] | ||||
Equity method investments | 8.1 | 8.9 | ||
Loss from equity method investments | (0.8) | $ (0.9) | ||
Wella Company | ||||
Debt and Equity Securities, FV-NI [Line Items] | ||||
Equity investments at fair value | $ 1,064 | $ 1,060 | ||
Ownership percentage | 25.90% | 25.90% |
EQUITY INVESTMENTS - Narrative
EQUITY INVESTMENTS - Narrative (Details) $ in Millions | Jul. 18, 2023 USD ($) |
Disposal Group, Held-for-Sale, Not Discontinued Operations | Wella Company | |
Schedule of Equity Method Investments [Line Items] | |
Cash proceeds from divestiture | $ 150 |
Wella Company | Coty Inc. | |
Schedule of Equity Method Investments [Line Items] | |
Ownership percentage | 3.60% |
EQUITY INVESTMENTS - Summarized
EQUITY INVESTMENTS - Summarized Statements of Operations Information (Details) - USD ($) $ in Millions | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Debt and Equity Securities, FV-NI [Line Items] | ||
Net revenues | $ 1,641.4 | $ 1,390 |
Gross profit | 1,041.9 | 888.7 |
Operating income | 197.5 | 171.9 |
(Loss) income before income taxes | 51.1 | 204.2 |
Net (loss) income | 10.2 | 134.5 |
KKW Beauty And Wella | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Gross profit | 426.8 | 394.6 |
Net (loss) income | (16.7) | 16 |
KKW Beauty And Wella | ||
Debt and Equity Securities, FV-NI [Line Items] | ||
Net revenues | 637.3 | 596.6 |
Operating income | 44.9 | 61 |
(Loss) income before income taxes | $ (6.8) | $ 20 |
EQUITY INVESTMENTS - Schedule_2
EQUITY INVESTMENTS - Schedule of Movement in Equity Investments (Details) - Wella Company $ in Millions | 3 Months Ended |
Sep. 30, 2023 USD ($) | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | |
Balance as of June 30, 2023 | $ 1,060 |
Total gains included in earnings | 4 |
Balance as of September 30, 2023 | $ 1,064 |
EQUITY INVESTMENTS - Schedule_3
EQUITY INVESTMENTS - Schedule of Significant Unobservable Inputs used in Level 3 Valuation (Details) - Wella Company $ in Millions | Sep. 30, 2023 USD ($) | Jun. 30, 2023 USD ($) |
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Fair value | $ 1,064 | $ 1,060 |
Fair Value, Inputs, Level 3 | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Fair value | $ 1,064 | |
Fair Value, Inputs, Level 3 | Discounted cash flows | Discount rate | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Unobservable input percentage | 0.1050 | |
Fair Value, Inputs, Level 3 | Discounted cash flows | Growth rate | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Unobservable input percentage | 0.018 | |
Fair Value, Inputs, Level 3 | Discounted cash flows | Growth rate | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Unobservable input percentage | 0.092 | |
Fair Value, Inputs, Level 3 | Market multiple | Revenue multiple | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Unobservable input percentage | 2.1 | |
Fair Value, Inputs, Level 3 | Market multiple | Revenue multiple | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Unobservable input percentage | 2.3 | |
Fair Value, Inputs, Level 3 | Market multiple | EBITDA multiple | Minimum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Unobservable input percentage | 10.4 | |
Fair Value, Inputs, Level 3 | Market multiple | EBITDA multiple | Maximum | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Unobservable input percentage | 13.9 |
GOODWILL AND OTHER INTANGIBLE_3
GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Changes in Goodwill (Details) $ in Millions | 3 Months Ended |
Sep. 30, 2023 USD ($) | |
Goodwill [Roll Forward] | |
Gross beginning balance | $ 8,028 |
Accumulated impairments beginning balance | (4,040.1) |
Net beginning balance | 3,987.9 |
Foreign currency translation | (60.4) |
Gross ending balance | 7,967.6 |
Accumulated impairments ending balance | (4,040.1) |
Net ending balance | 3,927.5 |
Prestige | |
Goodwill [Roll Forward] | |
Gross beginning balance | 6,279.2 |
Accumulated impairments beginning balance | (3,110.3) |
Net beginning balance | 3,168.9 |
Foreign currency translation | (48.1) |
Gross ending balance | 6,231.1 |
Accumulated impairments ending balance | (3,110.3) |
Net ending balance | 3,120.8 |
Consumer Beauty | |
Goodwill [Roll Forward] | |
Gross beginning balance | 1,748.8 |
Accumulated impairments beginning balance | (929.8) |
Net beginning balance | 819 |
Foreign currency translation | (12.3) |
Gross ending balance | 1,736.5 |
Accumulated impairments ending balance | (929.8) |
Net ending balance | $ 806.7 |
GOODWILL AND OTHER INTANGIBLE_4
GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Other Intangible Assets, Net (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Jun. 30, 2023 |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Indefinite-lived other intangible assets | $ 940.8 | $ 950.8 |
Finite-lived other intangible assets, net | 2,747.6 | 2,847.2 |
Total Other intangible assets, net | $ 3,688.4 | $ 3,798 |
GOODWILL AND OTHER INTANGIBLE_5
GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Schedule of Indefinite Lived Intangible Assets (Details) $ in Millions | 3 Months Ended |
Sep. 30, 2023 USD ($) | |
Indefinite-lived Intangible Assets [Roll Forward] | |
Gross beginning balance | $ 1,895.7 |
Accumulated impairments beginning balance | (944.9) |
Net beginning balance | 950.8 |
Foreign currency translation | (10) |
Gross ending balance | 1,885.7 |
Accumulated impairments ending balance | (944.9) |
Net ending balance | 940.8 |
Trademarks | |
Indefinite-lived Intangible Assets [Roll Forward] | |
Gross beginning balance | 1,895.7 |
Accumulated impairments beginning balance | (944.9) |
Net beginning balance | 950.8 |
Foreign currency translation | (10) |
Gross ending balance | 1,885.7 |
Accumulated impairments ending balance | (944.9) |
Net ending balance | $ 940.8 |
GOODWILL AND OTHER INTANGIBLE_6
GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Schedule of Intangible Assets Subject to Amortization (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Jun. 30, 2023 |
Finite-Lived Intangible Assets [Line Items] | ||
Cost | $ 4,827.6 | $ 4,905.4 |
Accumulated Amortization | (2,054.4) | (2,032.6) |
Accumulated Impairment | (25.6) | (25.6) |
Net | 2,747.6 | 2,847.2 |
License agreements and collaboration agreements | ||
Finite-Lived Intangible Assets [Line Items] | ||
Cost | 3,690.5 | 3,756.2 |
Accumulated Amortization | (1,301.3) | (1,282.6) |
Accumulated Impairment | (19.6) | (19.6) |
Net | 2,369.6 | 2,454 |
Customer relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Cost | 742.2 | 750.6 |
Accumulated Amortization | (507.6) | (505.9) |
Accumulated Impairment | (5.5) | (5.5) |
Net | 229.1 | 239.2 |
Trademarks | ||
Finite-Lived Intangible Assets [Line Items] | ||
Cost | 310.9 | 313 |
Accumulated Amortization | (182.7) | (180.6) |
Accumulated Impairment | (0.5) | (0.5) |
Net | 127.7 | 131.9 |
Product formulations and technology | ||
Finite-Lived Intangible Assets [Line Items] | ||
Cost | 84 | 85.6 |
Accumulated Amortization | (62.8) | (63.5) |
Accumulated Impairment | 0 | 0 |
Net | $ 21.2 | $ 22.1 |
GOODWILL AND OTHER INTANGIBLE_7
GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Narrative (Details) - USD ($) $ in Millions | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ||
Amortization expense | $ 48.6 | $ 47.3 |
LEASES - Narrative (Details)
LEASES - Narrative (Details) | Sep. 30, 2023 |
Minimum | |
Lessee, Lease, Description [Line Items] | |
Lessee, operating lease, term of contract | 4 years |
Maximum | |
Lessee, Lease, Description [Line Items] | |
Lessee, operating lease, term of contract | 25 years |
LEASES - Lease cost (Details)
LEASES - Lease cost (Details) - USD ($) $ in Millions | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Lease Cost: | ||
Operating lease cost | $ 19.1 | $ 19.2 |
Short-term lease cost | 0.3 | 0.2 |
Variable lease cost | 10.8 | 8.6 |
Sublease income | (3.9) | (3.8) |
Net lease cost | 26.3 | 24.2 |
Other information: | ||
Operating cash outflows from operating leases | (19.2) | (21.7) |
Right-of-use assets obtained in exchange for lease obligations | $ 15 | $ 7.6 |
Weighted-average remaining lease term - real estate | 7 years | 7 years 7 months 6 days |
Weighted-average discount rate - real estate leases | 4.29% | 4.02% |
LEASES - Minimum lease payments
LEASES - Minimum lease payments (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Jun. 30, 2023 |
Minimum lease payments | ||
2024, remaining | $ 55.7 | |
2025 | 62.3 | |
2026 | 53.9 | |
2027 | 46 | |
2028 | 33.8 | |
Thereafter | 105.7 | |
Total future lease payments | 357.4 | |
Less: imputed interest | (53.2) | |
Total present value of lease liabilities | 304.2 | |
Current operating lease liabilities | 59.9 | $ 65.6 |
Long-term operating lease liabilities | 244.3 | $ 247.5 |
Total operating lease liabilities | $ 304.2 |
DEBT - Schedule of Debt (Detail
DEBT - Schedule of Debt (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Jun. 30, 2023 |
Debt Instrument [Line Items] | ||
Short-term debt | $ 6 | $ 0 |
Long-term debt | 4,199.7 | |
Brazilian Credit Facilities | 31.9 | 31.9 |
Other long-term debt and finance lease obligations | 6.4 | 7.1 |
Total debt | 4,212.1 | 4,281.6 |
Less: Short-term debt and current portion of long-term debt | (40.8) | (57.9) |
Total Long-term debt | 4,171.3 | 4,223.7 |
Less: Unamortized financing fees and discounts on long-term debt | (75.9) | (45.5) |
Total Long-term debt, net | 4,095.4 | 4,178.2 |
Senior Secured Notes | 2026 Dollar Senior Secured Notes due April 2026 | ||
Debt Instrument [Line Items] | ||
Long-term debt | 900 | 900 |
Senior Secured Notes | 2026 Euro Senior Secured Notes due April 2026 | ||
Debt Instrument [Line Items] | ||
Long-term debt | 740.3 | 761 |
Senior Secured Notes | 2028 Euro Senior Secured Notes due September 2028 | ||
Debt Instrument [Line Items] | ||
Long-term debt | 528.8 | 0 |
Senior Secured Notes | 2029 Dollar Senior Secured Notes due January 2029 | ||
Debt Instrument [Line Items] | ||
Long-term debt | 500 | 500 |
Senior Secured Notes | 2030 Dollar Senior Secured Notes due July 2030 | ||
Debt Instrument [Line Items] | ||
Long-term debt | 750 | 0 |
Line of Credit | 2023 Coty Revolving Credit Facility due July 2028 | Revolving Credit Facility | ||
Debt Instrument [Line Items] | ||
Long-term debt | 85 | 0 |
Line of Credit | 2021 Coty Revolving Credit Facility due April 2025 | Revolving Credit Facility | ||
Debt Instrument [Line Items] | ||
Long-term debt | 0 | 228.9 |
Line of Credit | 2018 Coty Term B Facility due April 2025 | Term Loan | ||
Debt Instrument [Line Items] | ||
Long-term debt | 0 | 1,183.7 |
Line of Credit | 2026 Dollar Notes due April 2026 | Term Loan | ||
Debt Instrument [Line Items] | ||
Long-term debt | 473 | 473 |
Line of Credit | 2026 Euro Notes due April 2026 | Term Loan | ||
Debt Instrument [Line Items] | ||
Long-term debt | $ 190.7 | $ 196 |
DEBT - Narrative (Details)
DEBT - Narrative (Details) | 3 Months Ended | |||||||||||||||||
Aug. 03, 2023 USD ($) | Aug. 03, 2023 EUR (€) | Jul. 26, 2023 USD ($) | Jul. 11, 2023 USD ($) tranche | Nov. 30, 2021 USD ($) | Jun. 16, 2021 EUR (€) | Apr. 21, 2021 USD ($) | Apr. 05, 2018 USD ($) | Sep. 30, 2023 USD ($) fiscalQuarter | Sep. 30, 2022 USD ($) | Sep. 19, 2023 USD ($) | Sep. 19, 2023 EUR (€) | Jul. 26, 2023 EUR (€) | Jul. 11, 2023 EUR (€) tranche | Jun. 30, 2023 USD ($) | Dec. 07, 2022 USD ($) | Dec. 07, 2022 EUR (€) | Apr. 05, 2018 EUR (€) | |
Debt Instrument [Line Items] | ||||||||||||||||||
Short-term debt | $ 6,000,000 | $ 0 | ||||||||||||||||
Long-term debt | 4,199,700,000 | |||||||||||||||||
Deferred financing fees write-offs | 5,200,000 | $ 0 | ||||||||||||||||
Debt discount capitalized | $ 40,400,000 | $ 0 | ||||||||||||||||
Line of Credit | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Total net leverage ratio, material acquisition, number of fiscal quarters | fiscalQuarter | 4 | |||||||||||||||||
Total net leverage ratio, after material acquisition | fiscalQuarter | 2 | |||||||||||||||||
Line of Credit | Maximum | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Applicable leverage ratio following the closing of any material acquisition | 5.95 | |||||||||||||||||
Line of Credit | Minimum | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Applicable leverage ratio following the closing of any material acquisition | 1 | |||||||||||||||||
Senior Unsecured Notes | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Interest rate, stated percentage | 5.75% | 5.75% | ||||||||||||||||
Redemption price, percentage | 101% | |||||||||||||||||
2018 Coty Credit Agreement | Line of Credit | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Debt refinancing | $ 2,000,000,000 | |||||||||||||||||
Number of tranches | tranche | 2 | 2 | ||||||||||||||||
Credit spread adjustment | 0.10% | |||||||||||||||||
2018 Coty Credit Agreement | Line of Credit | Refinancing in Dollars and Certain Other Currencies | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Aggregate principal amount | $ 1,670,000,000 | |||||||||||||||||
2018 Coty Credit Agreement | Line of Credit | Refinancing in Euros | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Aggregate principal amount | € | € 300,000,000 | |||||||||||||||||
2030 Dollar Senior Secured Notes, Due April 2030 | Senior Unsecured Notes | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Debt Instrument, face amount | $ 750,000,000 | |||||||||||||||||
Interest rate, stated percentage | 6.625% | 6.625% | ||||||||||||||||
Proceeds from issuance of senior long-term debt | $ 740,600,000 | |||||||||||||||||
2018 Coty Term B Facility, Dollar Portion | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Long-term debt | 715,500,000 | |||||||||||||||||
2018 Coty Term B Facility, Euro Portion | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Long-term debt | $ 25,100,000 | € 22,600,000 | ||||||||||||||||
2028 Euro Senior Secured Notes | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Debt Instrument, face amount | $ 493,800,000 | |||||||||||||||||
2028 Euro Senior Secured Notes | Senior Unsecured Notes | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Debt Instrument, face amount | € | € 500,000,000 | |||||||||||||||||
Term Loan B Facility, Due April 2025 | Line of Credit | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Repayments of debt | $ 446,100,000 | € 408,000,000 | ||||||||||||||||
2026 Dollar Senior Secured Notes due April 2026 | Senior Unsecured Notes | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Debt Instrument, face amount | $ 900,000,000 | |||||||||||||||||
Interest rate, stated percentage | 5% | |||||||||||||||||
Proceeds from issuance of senior long-term debt | $ 900,000,000 | |||||||||||||||||
Long-term debt | $ 900,000,000 | 900,000,000 | ||||||||||||||||
Debt instrument, early redemption premium, percent of outstanding principal amount | 1% | |||||||||||||||||
Debt instrument, base redemption price, percentage | 100% | |||||||||||||||||
2026 Dollar Senior Secured Notes due April 2026 | Senior Unsecured Notes | Bund Rate | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Basis spread on variable rate, percentage | 0.50% | |||||||||||||||||
2026 Euro Senior Secured Notes due April 2026 | Senior Unsecured Notes | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Debt Instrument, face amount | € | € 700,000,000 | |||||||||||||||||
Interest rate, stated percentage | 3.875% | |||||||||||||||||
Proceeds from issuance of senior long-term debt | € | € 700,000,000 | |||||||||||||||||
Long-term debt | 740,300,000 | 761,000,000 | ||||||||||||||||
Debt instrument, early redemption premium, percent of outstanding principal amount | 1% | |||||||||||||||||
Debt instrument, base redemption price, percentage | 100% | |||||||||||||||||
2026 Euro Senior Secured Notes due April 2026 | Senior Unsecured Notes | US Treasury (UST) Interest Rate | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Basis spread on variable rate, percentage | 0.50% | |||||||||||||||||
2029 Dollar Senior Secured Notes due January 2029 | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Proceeds from issuance of senior long-term debt | $ 500,000,000 | |||||||||||||||||
2029 Dollar Senior Secured Notes due January 2029 | Senior Unsecured Notes | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Debt Instrument, face amount | $ 500,000,000 | |||||||||||||||||
Interest rate, stated percentage | 4.75% | |||||||||||||||||
Long-term debt | 500,000,000 | 500,000,000 | ||||||||||||||||
Debt instrument, early redemption premium, percent of outstanding principal amount | 1% | |||||||||||||||||
Debt instrument, base redemption price, percentage | 100% | |||||||||||||||||
2029 Dollar Senior Secured Notes due January 2029 | Senior Unsecured Notes | US Treasury (UST) Interest Rate | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Basis spread on variable rate, percentage | 0.50% | |||||||||||||||||
2028 Euro Senior Secured Notes due September 2028 | Senior Unsecured Notes | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Long-term debt | $ 528,800,000 | 0 | ||||||||||||||||
Debt instrument, early redemption premium, percent of outstanding principal amount | 1% | |||||||||||||||||
Debt instrument, base redemption price, percentage | 100% | |||||||||||||||||
2028 Euro Senior Secured Notes due September 2028 | Senior Unsecured Notes | US Treasury (UST) Interest Rate | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Basis spread on variable rate, percentage | 0.50% | |||||||||||||||||
2030 Dollar Senior Secured Notes due July 2030 | Senior Unsecured Notes | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Long-term debt | $ 750,000,000 | 0 | ||||||||||||||||
Debt instrument, early redemption premium, percent of outstanding principal amount | 1% | |||||||||||||||||
Debt instrument, base redemption price, percentage | 100% | |||||||||||||||||
2030 Dollar Senior Secured Notes due July 2030 | Senior Unsecured Notes | US Treasury (UST) Interest Rate | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Basis spread on variable rate, percentage | 0.50% | |||||||||||||||||
2018 Coty Term A Facility | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Aggregate principal amount | € | € 2,035,000,000 | |||||||||||||||||
2018 Coty Term A Facility | Line of Credit | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Aggregate principal amount | $ 1,000,000,000 | |||||||||||||||||
2018 Coty Term B Facility | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Aggregate principal amount | € | € 850,000,000 | |||||||||||||||||
2018 Coty Term B Facility | Line of Credit | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Aggregate principal amount | 1,400,000,000 | |||||||||||||||||
2026 Dollar Notes | Senior Unsecured Notes | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Debt Instrument, face amount | $ 550,000,000 | |||||||||||||||||
Interest rate, stated percentage | 6.50% | 6.50% | ||||||||||||||||
2026 Dollar Notes | Cash Tender Offers | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Long-term debt | $ 77,000,000 | |||||||||||||||||
2023 Euro Notes | Senior Unsecured Notes | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Debt Instrument, face amount | € | € 550,000,000 | |||||||||||||||||
Interest rate, stated percentage | 4% | 4% | ||||||||||||||||
2026 Euro Notes | Senior Unsecured Notes | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Debt Instrument, face amount | € | € 250,000,000 | |||||||||||||||||
Interest rate, stated percentage | 4.75% | 4.75% | ||||||||||||||||
2026 Euro Notes | Cash Tender Offers | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Long-term debt | $ 72,200,000 | € 69,700,000 | ||||||||||||||||
Letter of Credit | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Undrawn letters of credit and bank guarantees | $ 6,800,000 | 7,200,000 | ||||||||||||||||
Letter of Credit | 2023 Coty Revolving Credit Facility | Line of Credit | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Aggregate principal amount | $ 150,000,000 | |||||||||||||||||
Bank Guarantee | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Undrawn letters of credit and bank guarantees | $ 18,500,000 | $ 16,300,000 | ||||||||||||||||
Swingline loans | 2023 Coty Revolving Credit Facility | Line of Credit | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Aggregate principal amount | 150,000,000 | |||||||||||||||||
Incurrence Incremental Facilities | 2023 Coty Revolving Credit Facility | Line of Credit | ||||||||||||||||||
Debt Instrument [Line Items] | ||||||||||||||||||
Aggregate principal amount | $ 1,700,000,000 | |||||||||||||||||
Net leverage ratio | 3 |
DEBT - Debt Instrument Redempti
DEBT - Debt Instrument Redemption (Details) - Senior Secured Notes | 3 Months Ended | |
Apr. 05, 2018 | Sep. 30, 2023 | |
Debt Instrument [Line Items] | ||
Redemption price, percentage | 101% | |
2026 Dollar Senior Secured Notes due April 2026 | Debt Instrument, Redemption, Period Four | ||
Debt Instrument [Line Items] | ||
Redemption price, percentage | 101.25% | |
2026 Dollar Senior Secured Notes due April 2026 | Debt Instrument, Redemption, Period Five | ||
Debt Instrument [Line Items] | ||
Redemption price, percentage | 100% | |
2026 Euro Senior Secured Notes due April 2026 | Debt Instrument, Redemption, Period Four | ||
Debt Instrument [Line Items] | ||
Redemption price, percentage | 100.969% | |
2026 Euro Senior Secured Notes due April 2026 | Debt Instrument, Redemption, Period Five | ||
Debt Instrument [Line Items] | ||
Redemption price, percentage | 100% | |
2028 Euro Senior Secured Notes due September 2028 | Debt Instrument, Redemption, Period Five | ||
Debt Instrument [Line Items] | ||
Redemption price, percentage | 102.875% | |
2028 Euro Senior Secured Notes due September 2028 | Debt Instrument Redemption Period Six | ||
Debt Instrument [Line Items] | ||
Redemption price, percentage | 101.438% | |
2028 Euro Senior Secured Notes due September 2028 | Debt Instrument Redemption Period Year Seven | ||
Debt Instrument [Line Items] | ||
Redemption price, percentage | 100% | |
2028 Euro Senior Secured Notes due September 2028 | Debt Instrument Redemption Period After Year Seven | ||
Debt Instrument [Line Items] | ||
Redemption price, percentage | 100% | |
2029 Dollar Senior Secured Notes due January 2029 | Debt Instrument, Redemption, Period Five | ||
Debt Instrument [Line Items] | ||
Redemption price, percentage | 102.375% | |
2029 Dollar Senior Secured Notes due January 2029 | Debt Instrument Redemption Period Six | ||
Debt Instrument [Line Items] | ||
Redemption price, percentage | 101.188% | |
2029 Dollar Senior Secured Notes due January 2029 | Debt Instrument Redemption Period Year Seven | ||
Debt Instrument [Line Items] | ||
Redemption price, percentage | 100% | |
2029 Dollar Senior Secured Notes due January 2029 | Debt Instrument Redemption Period After Year Seven | ||
Debt Instrument [Line Items] | ||
Redemption price, percentage | 100% | |
2030 Dollar Senior Secured Notes due July 2030 | Debt Instrument Redemption Period Six | ||
Debt Instrument [Line Items] | ||
Redemption price, percentage | 103.313% | |
2030 Dollar Senior Secured Notes due July 2030 | Debt Instrument Redemption Period Year Seven | ||
Debt Instrument [Line Items] | ||
Redemption price, percentage | 101.656% | |
2030 Dollar Senior Secured Notes due July 2030 | Debt Instrument Redemption Period After Year Seven | ||
Debt Instrument [Line Items] | ||
Redemption price, percentage | 100% |
DEBT - Pricing Tiers (Details)
DEBT - Pricing Tiers (Details) | 3 Months Ended |
Sep. 30, 2023 | |
Pricing Tier One | SOFR | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 1.125% |
Pricing Tier One | Alternative Base Rate | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 0.125% |
Pricing Tier Two | SOFR | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 1.25% |
Pricing Tier Two | Alternative Base Rate | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 0.25% |
Pricing Tier Three | SOFR | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 1.50% |
Pricing Tier Three | Alternative Base Rate | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 0.50% |
Pricing Tier Four | SOFR | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 1.75% |
Pricing Tier Four | Alternative Base Rate | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 0.75% |
Pricing Tier Five | SOFR | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 2% |
Pricing Tier Five | Alternative Base Rate | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 1% |
Pricing Tier One | SOFR | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 2% |
Pricing Tier One | Alternative Base Rate | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 1% |
Pricing Tier Two | SOFR | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 1.75% |
Pricing Tier Two | Alternative Base Rate | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 0.75% |
Pricing Tier Three | SOFR | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 1.50% |
Pricing Tier Three | Alternative Base Rate | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 0.50% |
Pricing Tier Four | SOFR | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 1.25% |
Pricing Tier Four | Alternative Base Rate | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 0.25% |
Pricing Tier Five | SOFR | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 1.125% |
Pricing Tier Five | Alternative Base Rate | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 0.125% |
Pricing Tier Six | SOFR | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 1% |
Pricing Tier Six | Alternative Base Rate | |
Debt Instrument [Line Items] | |
Basis spread on variable rate, percentage | 0% |
Minimum | Pricing Tier One | |
Debt Instrument [Line Items] | |
Net leverage ratio | 4.75 |
Minimum | Pricing Tier Two | |
Debt Instrument [Line Items] | |
Net leverage ratio | 4 |
Minimum | Pricing Tier Three | |
Debt Instrument [Line Items] | |
Net leverage ratio | 2.75 |
Minimum | Pricing Tier Four | |
Debt Instrument [Line Items] | |
Net leverage ratio | 2 |
Minimum | Pricing Tier Five | |
Debt Instrument [Line Items] | |
Net leverage ratio | 1.50 |
Maximum | Pricing Tier Two | |
Debt Instrument [Line Items] | |
Net leverage ratio | 4.75 |
Maximum | Pricing Tier Three | |
Debt Instrument [Line Items] | |
Net leverage ratio | 4 |
Maximum | Pricing Tier Four | |
Debt Instrument [Line Items] | |
Net leverage ratio | 2.75 |
Maximum | Pricing Tier Five | |
Debt Instrument [Line Items] | |
Net leverage ratio | 2 |
Maximum | Pricing Tier Six | |
Debt Instrument [Line Items] | |
Net leverage ratio | 1.50 |
DEBT - Schedule of Fair Value o
DEBT - Schedule of Fair Value of Debt (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Jun. 30, 2023 |
2018 Coty Credit Agreement | Carrying Amount | ||
Debt Instrument [Line Items] | ||
Fair value of debt | $ 85 | $ 1,412.6 |
2018 Coty Credit Agreement | Fair Value | ||
Debt Instrument [Line Items] | ||
Fair value of debt | 85 | 1,393.5 |
Senior Secured Notes | Carrying Amount | ||
Debt Instrument [Line Items] | ||
Fair value of debt | 3,419.1 | 2,161 |
Senior Secured Notes | Fair Value | ||
Debt Instrument [Line Items] | ||
Fair value of debt | 3,305 | 2,066.9 |
Senior Unsecured Notes | Carrying Amount | ||
Debt Instrument [Line Items] | ||
Fair value of debt | 663.7 | 669 |
Senior Unsecured Notes | Fair Value | ||
Debt Instrument [Line Items] | ||
Fair value of debt | 657 | 661.5 |
Brazilian Credit Facilities | Carrying Amount | ||
Debt Instrument [Line Items] | ||
Fair value of debt | 31.9 | 31.9 |
Brazilian Credit Facilities | Fair Value | ||
Debt Instrument [Line Items] | ||
Fair value of debt | $ 32.1 | $ 32.2 |
DEBT - Schedule of Maturities o
DEBT - Schedule of Maturities of Long-Term Debt (Details) $ in Millions | Sep. 30, 2023 USD ($) |
Debt Disclosure [Abstract] | |
2024, remaining | $ 31.9 |
2025 | 0 |
2026 | 2,304 |
2027 | 0 |
2028 | 0 |
Thereafter | 1,863.8 |
Total | $ 4,199.7 |
DEBT - Total Net Leverage Ratio
DEBT - Total Net Leverage Ratio (Details) | 3 Months Ended |
Sep. 30, 2023 | |
September 30, 2023 through April 5, 2025 | |
Debt Instrument [Line Items] | |
Net leverage ratio | 4 |
INTEREST EXPENSE, NET (Details)
INTEREST EXPENSE, NET (Details) - USD ($) $ in Millions | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Interest Income (Expense), Net [Abstract] | ||
Interest expense | $ 66.8 | $ 57.6 |
Foreign exchange losses, net of derivative contracts | 8.2 | 11.9 |
Interest income | (5.2) | (3.6) |
Total interest expense, net | $ 69.8 | $ 65.9 |
EMPLOYEE BENEFIT PLANS - Schedu
EMPLOYEE BENEFIT PLANS - Schedule of Components of Net Periodic Benefit Cost (Details) - USD ($) $ in Millions | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Defined Benefit Plan Disclosure [Line Items] | ||
Service cost | $ 1.4 | $ 1.4 |
Interest cost | 3.8 | 3.3 |
Expected return on plan assets | (1.2) | (0.9) |
Amortization of prior service credit | (0.1) | (0.1) |
Amortization of net (gain) loss | (1.4) | (1.4) |
Net periodic benefit cost (credit) | 2.5 | 2.3 |
Other Post- Employment Benefits | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Service cost | 0.1 | 0.2 |
Interest cost | 0.4 | 0.4 |
Expected return on plan assets | 0 | 0 |
Amortization of prior service credit | (0.1) | (0.1) |
Amortization of net (gain) loss | (0.6) | (0.5) |
Net periodic benefit cost (credit) | (0.2) | 0 |
U.S. | Pension Plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Service cost | 0 | 0 |
Interest cost | 0.2 | 0.2 |
Expected return on plan assets | 0 | 0 |
Amortization of prior service credit | 0 | 0 |
Amortization of net (gain) loss | (0.2) | (0.7) |
Net periodic benefit cost (credit) | 0 | (0.5) |
International | Pension Plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Service cost | 1.3 | 1.2 |
Interest cost | 3.2 | 2.7 |
Expected return on plan assets | (1.2) | (0.9) |
Amortization of prior service credit | 0 | 0 |
Amortization of net (gain) loss | (0.6) | (0.2) |
Net periodic benefit cost (credit) | $ 2.7 | $ 2.8 |
DERIVATIVE INSTRUMENTS - Narrat
DERIVATIVE INSTRUMENTS - Narrative (Details) € in Millions | 1 Months Ended | ||||||
Sep. 30, 2020 USD ($) | Sep. 30, 2023 USD ($) | Sep. 30, 2023 EUR (€) | Jun. 30, 2023 USD ($) | Jun. 30, 2023 EUR (€) | Dec. 31, 2022 USD ($) | Jun. 30, 2022 USD ($) | |
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||||
Authorized repurchase amount | $ 196,000,000 | $ 200,000,000 | |||||
Accumulated other comprehensive income (loss) | $ (777,400,000) | $ (662,400,000) | |||||
Net investment hedge | |||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||||
Foreign exchange risk exposure amount (in Euros) | € | € 835.9 | € 701.3 | |||||
Net investment hedge | Other Foreign Currency Translation Adjustments | |||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||||
Accumulated other comprehensive income (loss) | 5,500,000 | (12,200,000) | |||||
Foreign exchange forward contracts | |||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||||
Cash flow hedges in AOCI/(L), net of tax | 2,200,000 | 700,000 | |||||
Cash flow hedge to be reclassified during next 12 months | 1,500,000 | ||||||
Foreign exchange forward contracts | Net investment hedge | |||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||||
Notional amount | 29,100,000 | 28,000,000 | |||||
Foreign exchange forward contracts | Net investment hedge | Other Foreign Currency Translation Adjustments | |||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||||
Accumulated other comprehensive income (loss) | (37,600,000) | (37,600,000) | |||||
Cross-currency swap contracts | Net investment hedge | |||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||||
Notional amount | 1,465,100,000 | 1,653,500,000 | |||||
Notional amount terminated | $ 550,000,000 | ||||||
Payment for termination of derivative | $ 37,600,000 | ||||||
Interest rate swap contracts | Interest Rate Risk | |||||||
Derivative Instruments and Hedging Activities Disclosures [Line Items] | |||||||
Notional amount | $ 200,000,000 | $ 200,000,000 |
DERIVATIVE INSTRUMENTS - Gains
DERIVATIVE INSTRUMENTS - Gains and Losses Recognized in OCI (Details) - USD ($) $ in Millions | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Derivative [Line Items] | ||
Net investment hedges | $ 17.7 | $ (5.3) |
Foreign exchange forward contracts | ||
Derivative [Line Items] | ||
Gain (Loss) Recognized in OCI | 1.1 | 1.7 |
Interest rate swap contracts | ||
Derivative [Line Items] | ||
Gain (Loss) Recognized in OCI | $ 1 | $ 1.7 |
DERIVATIVE INSTRUMENTS - Amount
DERIVATIVE INSTRUMENTS - Amount of Gains and Losses Reclassified from AOCI (Details) - USD ($) $ in Millions | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Cost of sales | Foreign exchange forward contracts | ||
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | ||
Amount of gain (loss) reclassified from AOCI into income | $ (0.7) | $ (1.5) |
Cost of sales | Interest rate swap contracts | ||
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | ||
Amount of gain (loss) reclassified from AOCI into income | 0 | 0 |
Interest expense, net | Foreign exchange forward contracts | ||
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | ||
Amount of gain (loss) reclassified from AOCI into income | 0 | 0 |
Interest expense, net | Interest rate swap contracts | ||
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items] | ||
Amount of gain (loss) reclassified from AOCI into income | $ 0.6 | $ 1.8 |
DERIVATIVE INSTRUMENTS - Deriva
DERIVATIVE INSTRUMENTS - Derivatives Not Designated as Hedging (Details) - Foreign exchange forward contracts - USD ($) $ in Millions | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Selling, general and administrative expenses | ||
Derivative [Line Items] | ||
Gain (loss) recognized in operations | $ 0.1 | $ 0 |
Interest expense, net | ||
Derivative [Line Items] | ||
Gain (loss) recognized in operations | (29.4) | (34.2) |
Other (expense) income, net | ||
Derivative [Line Items] | ||
Gain (loss) recognized in operations | $ (75.7) | $ (52) |
EQUITY AND CONVERTIBLE PREFER_3
EQUITY AND CONVERTIBLE PREFERRED STOCK - Narrative (Details) € / shares in Units, $ / shares in Units, € in Millions | 3 Months Ended | ||||||||||||||
Oct. 02, 2023 USD ($) shares | Sep. 29, 2023 shares | Sep. 28, 2023 $ / shares shares | Sep. 18, 2023 shares | Oct. 29, 2021 shares | May 11, 2020 USD ($) $ / shares shares | Sep. 30, 2023 USD ($) class_of_stock vote $ / shares shares | Sep. 30, 2022 USD ($) | Oct. 02, 2023 EUR (€) | Sep. 28, 2023 € / shares | Jun. 30, 2023 USD ($) $ / shares shares | Dec. 31, 2022 USD ($) | Jun. 30, 2022 USD ($) | Nov. 16, 2020 shares | Feb. 03, 2016 USD ($) | |
Class of Stock [Line Items] | |||||||||||||||
Common stock, par value (in dollars per share) | $ / shares | $ 0.01 | $ 0.01 | |||||||||||||
Common stock, shares authorized (in shares) | shares | 1,250,000,000 | 1,250,000,000 | |||||||||||||
Common stock, shares outstanding (in shares) | shares | 888,000,000 | 852,800,000 | |||||||||||||
Issuance of common stock in connection with global offering, net of offering costs (in shares) | shares | 33,000,000 | ||||||||||||||
Common stock (in dollars per share) | $ / shares | $ 0.01 | ||||||||||||||
Shares issued (in dollars per share) | (per share) | $ 10.80 | € 10.28 | |||||||||||||
Conversion of stock (in shares) | shares | 30,000,000 | ||||||||||||||
Receivable from sale of stock | $ | $ 348,500,000 | $ 0 | |||||||||||||
Preferred stock, shares authorized (in shares) | shares | 20,000,000 | 20,000,000 | |||||||||||||
Number of classes of preferred stock | class_of_stock | 2 | ||||||||||||||
Preferred stock, par value (in dollars per share) | $ / shares | $ 0.01 | $ 0.01 | |||||||||||||
Preferred stock, shares outstanding (in shares) | shares | 1,000,000 | 1,000,000 | |||||||||||||
Preferred stock, shares issued (in shares) | shares | 1,000,000 | 1,000,000 | |||||||||||||
Preferred stock, value issued | $ | $ 0 | $ 0 | |||||||||||||
Dividends declared | $ | 3,300,000 | $ 3,300,000 | |||||||||||||
Authorized repurchase amount | $ | $ 196,000,000 | $ 200,000,000 | |||||||||||||
Employee taxes | $ | 100,000 | ||||||||||||||
Subsequent event | |||||||||||||||
Class of Stock [Line Items] | |||||||||||||||
Conversion of stock (in shares) | shares | 3,000,000 | ||||||||||||||
Deferred offering costs | $ 31,500,000 | € 299.8 | |||||||||||||
Underwriting fees | $ | 10,000,000 | ||||||||||||||
Professional fees | $ | $ 5,500,000 | ||||||||||||||
Additional Paid-in Capital | |||||||||||||||
Class of Stock [Line Items] | |||||||||||||||
Dividends declared | $ | 3,300,000 | 3,300,000 | |||||||||||||
Dividends payable | $ | $ 0 | ||||||||||||||
June 2022 Forward Contracts | |||||||||||||||
Class of Stock [Line Items] | |||||||||||||||
Authorized repurchase amount | $ | $ 200,000,000 | ||||||||||||||
December 2022 Forward Contracts | |||||||||||||||
Class of Stock [Line Items] | |||||||||||||||
Authorized repurchase amount | $ | $ 196,000,000 | ||||||||||||||
SOFR | June 2022 Forward Contracts | |||||||||||||||
Class of Stock [Line Items] | |||||||||||||||
Weighted average interest rate spread | 9.70% | ||||||||||||||
SOFR | December 2022 Forward Contracts | |||||||||||||||
Class of Stock [Line Items] | |||||||||||||||
Weighted average interest rate spread | 9.70% | ||||||||||||||
RSUs | |||||||||||||||
Class of Stock [Line Items] | |||||||||||||||
Preferred stock dividends declared and paid during the period | $ | $ 400,000 | ||||||||||||||
Restricted Stock Units and Phantom Units | Other Noncurrent Liabilities | |||||||||||||||
Class of Stock [Line Items] | |||||||||||||||
Dividends payable | $ | 100,000 | 100,000 | |||||||||||||
Restricted Stock Units and Phantom Units | Accrued Expenses and Other Current Liabilities | |||||||||||||||
Class of Stock [Line Items] | |||||||||||||||
Dividends payable | $ | $ 1,000,000 | 1,000,000 | |||||||||||||
CEO | RSUs | JAB Beauty B.V | |||||||||||||||
Class of Stock [Line Items] | |||||||||||||||
Shares contributed by related party (in shares) | shares | 5,000,000 | 10,000,000 | |||||||||||||
Common Class A | |||||||||||||||
Class of Stock [Line Items] | |||||||||||||||
Common stock, par value (in dollars per share) | $ / shares | $ 0.01 | ||||||||||||||
Votes per share | vote | 1 | ||||||||||||||
Common stock, shares authorized (in shares) | shares | 1,250,000,000 | ||||||||||||||
Common stock, shares outstanding (in shares) | shares | 888,000,000 | ||||||||||||||
Common Class A | Incremental Repurchase Program | |||||||||||||||
Class of Stock [Line Items] | |||||||||||||||
Authorized repurchase amount | $ | $ 500,000,000 | ||||||||||||||
Purchase of Class A Common Stock (in shares) | shares | 0 | ||||||||||||||
Share repurchase program, remaining authorized repurchase amount | $ | $ 396,800,000 | ||||||||||||||
Common Class A | JAB Beauty B.V | |||||||||||||||
Class of Stock [Line Items] | |||||||||||||||
Parent ownership percentage | 53% | ||||||||||||||
Series A Preferred Stock | |||||||||||||||
Class of Stock [Line Items] | |||||||||||||||
Votes per share | vote | 0 | ||||||||||||||
Preferred stock, shares authorized (in shares) | shares | 1,000,000 | ||||||||||||||
Preferred stock, par value (in dollars per share) | $ / shares | $ 0.01 | ||||||||||||||
Preferred stock, shares outstanding (in shares) | shares | 1,000,000 | ||||||||||||||
Preferred stock, shares issued (in shares) | shares | 1,000,000 | ||||||||||||||
Series A Preferred Stock | Other Noncurrent Liabilities | |||||||||||||||
Class of Stock [Line Items] | |||||||||||||||
Preferred stock, value issued | $ | $ 200,000 | ||||||||||||||
Series A-1 Preferred Stock | |||||||||||||||
Class of Stock [Line Items] | |||||||||||||||
Votes per share | vote | 0 | ||||||||||||||
Preferred stock, shares authorized (in shares) | shares | 0 | ||||||||||||||
Preferred stock, par value (in dollars per share) | $ / shares | $ 0.01 | ||||||||||||||
Preferred stock, shares outstanding (in shares) | shares | 0 | ||||||||||||||
Preferred stock, shares issued (in shares) | shares | 0 | ||||||||||||||
Series B Preferred Stock | |||||||||||||||
Class of Stock [Line Items] | |||||||||||||||
Preferred stock, par value (in dollars per share) | $ / shares | $ 0.01 | ||||||||||||||
Sale of stock, shares authorized (in shares) | shares | 1,000,000 | ||||||||||||||
Sale of stock, maximum purchase price received | $ | $ 1,000,000,000 | ||||||||||||||
Sale of stock, price per share (in dollars per share) | $ / shares | $ 1,000 | ||||||||||||||
Preferred stock, dividend rate | 9% | ||||||||||||||
Dividends declared | $ | $ 3,300,000 | 3,300,000 | |||||||||||||
Preferred stock dividends declared and paid during the period | $ | 3,300,000 | $ 3,300,000 | |||||||||||||
Dividends payable | $ | $ 3,300,000 | $ 3,300,000 | |||||||||||||
Series B Preferred Stock | KKR | HFS | |||||||||||||||
Class of Stock [Line Items] | |||||||||||||||
Preferred stock, shares issued (in shares) | shares | 146,057 | ||||||||||||||
Series B Preferred Stock | JAB Beauty B.V | |||||||||||||||
Class of Stock [Line Items] | |||||||||||||||
Conversion of stock (in shares) | shares | 3,000,000 |
EQUITY AND CONVERTIBLE PREFER_4
EQUITY AND CONVERTIBLE PREFERRED STOCK - Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | ||
Balance, beginning of period | $ 3,997.4 | $ 3,345.8 |
Other comprehensive income (loss) before reclassifications | (114.4) | (265.1) |
Net amounts reclassified from AOCI/(L) | (0.6) | (1.1) |
Net current-period other comprehensive income (loss) | (115) | (266.2) |
Ending balance | 3,908.7 | 3,243.1 |
Total | ||
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | ||
Balance, beginning of period | (662.4) | (717.9) |
Ending balance | (777.4) | (984.1) |
Gain (Loss) on Cash Flow Hedges | ||
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | ||
Balance, beginning of period | 0.7 | 4.3 |
Other comprehensive income (loss) before reclassifications | 1.5 | 1.3 |
Net amounts reclassified from AOCI/(L) | 0 | (0.4) |
Net current-period other comprehensive income (loss) | 1.5 | 0.9 |
Ending balance | 2.2 | 5.2 |
(Loss) gain on Net Investment Hedge | ||
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | ||
Balance, beginning of period | (49.8) | 4.1 |
Other comprehensive income (loss) before reclassifications | 17.7 | (5.3) |
Net amounts reclassified from AOCI/(L) | 0 | 0 |
Net current-period other comprehensive income (loss) | 17.7 | (5.3) |
Ending balance | (32.1) | (1.2) |
Other Foreign Currency Translation Adjustments | ||
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | ||
Balance, beginning of period | (667.9) | (770.8) |
Other comprehensive income (loss) before reclassifications | (132.1) | (258.6) |
Net amounts reclassified from AOCI/(L) | 0 | 0 |
Net current-period other comprehensive income (loss) | (132.1) | (258.6) |
Ending balance | (800) | (1,029.4) |
Pension and Other Post-Employment Benefit Plans | ||
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | ||
Balance, beginning of period | 54.6 | 44.5 |
Other comprehensive income (loss) before reclassifications | (1.5) | (2.5) |
Net amounts reclassified from AOCI/(L) | (0.6) | (0.7) |
Net current-period other comprehensive income (loss) | (2.1) | (3.2) |
Ending balance | 52.5 | $ 41.3 |
Reclassification from accumulated other comprehensive income (loss), current period, before tax | (1.5) | |
Other comprehensive income (loss), tax | $ 0.9 |
SHARE-BASED COMPENSATION PLAN_2
SHARE-BASED COMPENSATION PLANS - Schedule of Share-based Compensation (Details) - USD ($) $ in Millions | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total share-based compensation expense | $ 29.7 | $ 31.1 |
Share-based compensation expense | 30.2 | 31.4 |
Additional Paid-in Capital | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Share-based compensation expense | 30.2 | 31.4 |
Equity plan expense | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total share-based compensation expense | 30.2 | 31.4 |
Equity plan expense | Additional Paid-in Capital | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Share-based compensation expense | 30.2 | 31.4 |
Liability plan (income) expense | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Total share-based compensation expense | $ (0.5) | $ (0.3) |
SHARE-BASED COMPENSATION PLAN_3
SHARE-BASED COMPENSATION PLANS - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | |||||||||
Sep. 28, 2023 | Sep. 18, 2023 | May 04, 2023 | Oct. 29, 2021 | Sep. 30, 2023 | Sep. 30, 2022 | Aug. 31, 2023 | Jun. 30, 2023 | Aug. 31, 2022 | Jun. 30, 2021 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Share-based compensation expense (income) | $ 29.7 | $ 31.1 | ||||||||
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||||||||
Common Class A | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Common stock, par value (in dollars per share) | $ 0.01 | |||||||||
Series A and A-1 Preferred Stock | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Share-based compensation expense (income) | $ (0.6) | (0.4) | ||||||||
Series A Preferred Stock | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Awards granted (in shares) | 0 | |||||||||
Series A-1 Preferred Stock | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Awards granted (in shares) | 0 | |||||||||
Stock Option | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Total unrecognized share-based compensation expense | $ 0.5 | |||||||||
Weighted-average period for unrecognized share-based compensation | 7 months 28 days | |||||||||
Restricted Stock | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Total unrecognized share-based compensation expense | $ 2.8 | |||||||||
Weighted-average period for unrecognized share-based compensation | 1 year 8 months 19 days | |||||||||
Share-based compensation expense (income) | $ 0.5 | 0.5 | ||||||||
Awards granted (in shares) | 0 | |||||||||
Restricted Stock Units and Other Share Awards | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Total unrecognized share-based compensation expense | $ 142.7 | |||||||||
Weighted-average period for unrecognized share-based compensation | 3 years 11 months 23 days | |||||||||
Share-based compensation expense (income) | $ 29.4 | 30.7 | ||||||||
Performance Restricted Stock Units | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Total unrecognized share-based compensation expense | $ 25.3 | |||||||||
Weighted-average period for unrecognized share-based compensation | 2 years 9 months 7 days | |||||||||
Share-based compensation expense (income) | $ 0.6 | 0 | ||||||||
Awards granted (in shares) | 2,100,000 | |||||||||
Performance Restricted Stock Units | CEO | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Share-based compensation expense (income) | $ 0.1 | 0 | ||||||||
Shares to be granted for restricted stock awards (in shares) | 2,083,333 | 10,416,665 | ||||||||
Performance objectives term | 3 years | |||||||||
Restricted Stock Units | CEO | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Share-based compensation expense (income) | 21 | 23.5 | ||||||||
Shares to be granted for restricted stock awards (in shares) | 10,416,667 | |||||||||
Restricted Stock Units | CEO | Second Restricted Stock Units Award | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Total unrecognized share-based compensation expense | $ 109.6 | |||||||||
Shares to be granted for restricted stock awards (in shares) | 10,416,667 | |||||||||
Award vesting period | 5 years | |||||||||
Restricted Stock Units | CEO | JAB Beauty B.V | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Shares contributed by related party (in shares) | 5,000,000 | 10,000,000 | ||||||||
Restricted Stock Units | CEO | Share-based Payment Arrangement, Tranche One | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Shares to be granted for restricted stock awards (in shares) | 10,000,000 | |||||||||
Restricted Stock Units | CEO | Share-based Payment Arrangement, Tranche One | Second Restricted Stock Units Award | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Award vesting rights percentage | 15% | |||||||||
Restricted Stock Units | CEO | Share-based Payment Arrangement, Tranche One | JAB Beauty B.V | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Shares contributed by related party (in shares) | 10,000,000 | |||||||||
Restricted Stock Units | CEO | Share-based Payment Arrangement, Tranche Two | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Shares to be granted for restricted stock awards (in shares) | 10,000,000 | |||||||||
Restricted Stock Units | CEO | Share-based Payment Arrangement, Tranche Two | First Restricted Stock Units Award | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Shares to be granted for restricted stock awards (in shares) | 5 | 10 | ||||||||
Restricted Stock Units | CEO | Share-based Payment Arrangement, Tranche Two | Second Restricted Stock Units Award | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Award vesting rights percentage | 15% | |||||||||
Restricted Stock Units | CEO | Share-based Payment Arrangement, Tranche Three | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Shares to be granted for restricted stock awards (in shares) | 10,000,000 | |||||||||
Restricted Stock Units | CEO | Share-based Payment Arrangement, Tranche Three | Second Restricted Stock Units Award | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Award vesting rights percentage | 20% | |||||||||
Restricted Stock Units | CEO | Share-based Payment Arrangement, Tranche Three | JAB Beauty B.V | First Restricted Stock Units Award | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Shares contributed by related party (in shares) | 5,000,000 | |||||||||
Restricted Stock Units | CEO | Share Based Payment Arrangement Tranche Four | Second Restricted Stock Units Award | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Award vesting rights percentage | 20% | |||||||||
Restricted Stock Units | CEO | Share Based Payment Arrangement Tranche Five | Second Restricted Stock Units Award | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Award vesting rights percentage | 30% | |||||||||
Restricted Stock Units | Common Class A | CEO | Second Restricted Stock Units Award | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Common stock, par value (in dollars per share) | $ 0.01 | |||||||||
Restricted Stock Units | Common Class A | CEO | Share-based Payment Arrangement, Tranche One | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Common stock, par value (in dollars per share) | $ 0.01 | |||||||||
Restricted Stock Units | Common Class A | CEO | Share-based Payment Arrangement, Tranche Two | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Common stock, par value (in dollars per share) | 0.01 | |||||||||
Restricted Stock Units | Common Class A | CEO | Share-based Payment Arrangement, Tranche Three | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Common stock, par value (in dollars per share) | $ 0.01 | |||||||||
Non-Qualified Options | ||||||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||||||
Share-based compensation expense (income) | $ (0.2) | $ 0.3 | ||||||||
Options granted (in shares) | 0 |
NET INCOME ATTRIBUTABLE TO CO_3
NET INCOME ATTRIBUTABLE TO COTY INC. PER COMMON SHARE (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions | 3 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
Amounts attributable to Coty Inc.: | ||
Net income attributable to Coty Inc. | $ 1.6 | $ 128.6 |
Convertible Series B Preferred Stock dividends | (3.3) | (3.3) |
Net (loss) income attributable to common stockholders | $ (1.7) | $ 125.3 |
Weighted-average common shares outstanding: | ||
Weighted-average common shares outstanding—Basic (in shares) | 854.3 | 842 |
Effect of dilutive stock options and Series A Preferred Stock (in shares) | 0 | 0 |
Effect of restricted stock and RSUs (in shares) | 0 | 16.5 |
Effect of Convertible Series B Preferred Stock (in shares) | 0 | 23.7 |
Effect of Forward Repurchase Contracts (in shares) | 0 | 0 |
Weighted-average common shares outstanding—Diluted (in shares) | 854.3 | 882.2 |
Earnings per common share: | ||
Earnings per common share - basic (in dollars per share) | $ 0 | $ 0.15 |
Earnings per common share - diluted (in dollars per share) | $ 0 | $ 0.15 |
Convertible Series B Preferred Stock dividends | $ 3.3 | $ 3.3 |
Antidilutive fair market value adjustments | $ 44.3 | $ 27.7 |
Stock Options and Series A Preferred Stock | ||
Earnings per common share: | ||
Anti-dilutive shares (in shares) | 6.2 | |
Forward Repurchase Contract | ||
Earnings per common share: | ||
Anti-dilutive shares (in shares) | 3.1 |
REDEEMABLE NONCONTROLLING INT_2
REDEEMABLE NONCONTROLLING INTERESTS (Details) - USD ($) $ in Millions | Sep. 30, 2023 | Jun. 30, 2023 | Sep. 30, 2022 | Jun. 30, 2022 |
Redeemable Noncontrolling Interest [Line Items] | ||||
Non-cash redeemable noncontrolling interest for business combinations | $ 98.6 | $ 93.5 | $ 69.3 | $ 69.8 |
Middle East Subsidiary | ||||
Redeemable Noncontrolling Interest [Line Items] | ||||
Ownership percentage by noncontrolling owners | 25% |
COMMITMENT AND CONTINGENCIES (D
COMMITMENT AND CONTINGENCIES (Details) R$ in Millions, $ in Millions | Sep. 30, 2023 USD ($) | Sep. 30, 2023 BRL (R$) | Aug. 31, 2023 USD ($) | Aug. 31, 2023 BRL (R$) | Jun. 30, 2023 USD ($) |
Loss Contingencies [Line Items] | |||||
Unrecognized tax benefits, income tax penalties and interest accrued | $ 34.4 | $ 33.1 | |||
Brazilian Tax Assessments | Pending Litigation | Foreign State Tax Authority | 2016-2017 | |||||
Loss Contingencies [Line Items] | |||||
Unrecognized tax benefits, income tax penalties and interest accrued | 0 | R$ 0.0 | |||
Brazilian Tax Assessments | Pending Litigation | Foreign State Tax Authority | 2017-2019 | |||||
Loss Contingencies [Line Items] | |||||
Unrecognized tax benefits, income tax penalties and interest accrued | 133.9 | 674.1 | |||
Brazilian Tax Assessments | Pending Litigation | Foreign State Tax Authority | 2016-2019 | |||||
Loss Contingencies [Line Items] | |||||
Unrecognized tax benefits, income tax penalties and interest accrued | 44.3 | 223 | |||
Brazilian Tax Assessments | Pending Litigation | Foreign State Tax Authority | 2016-2020 | |||||
Loss Contingencies [Line Items] | |||||
Unrecognized tax benefits, income tax penalties and interest accrued | 13 | 65.2 | |||
Brazilian Tax Assessments | Pending Litigation | Foreign State Tax Authority | Tax Years 2016 Through 2017 | |||||
Loss Contingencies [Line Items] | |||||
Unrecognized tax benefits, income tax penalties and interest accrued | $ 0.2 | R$ 1.1 | |||
Brazilian Tax Assessments | Pending Litigation | Foreign Federal Tax Authority | 2016-2017 | |||||
Loss Contingencies [Line Items] | |||||
Unrecognized tax benefits, income tax penalties and interest accrued | 82.4 | 414.6 | |||
Brazilian Tax Assessments | Pending Litigation | Foreign Federal Tax Authority | 2018-2019 | |||||
Loss Contingencies [Line Items] | |||||
Unrecognized tax benefits, income tax penalties and interest accrued | $ 110.5 | R$ 556.5 |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Jun. 30, 2023 | |
Related Party Transaction [Line Items] | |||
Gain on sale | $ (76.6) | $ 98.2 | |
Accounts receivable, related parties | 534.9 | $ 360.9 | |
Accounts payable | 1,375.4 | 1,444.7 | |
Other noncurrent liabilities | 343.5 | $ 325.4 | |
Share-based compensation expense (income) | 29.7 | 31.1 | |
Sublease income | 3.9 | 3.8 | |
KKR | |||
Related Party Transaction [Line Items] | |||
Gain on sale | 6.6 | ||
Accounts receivable, related parties | 4.1 | ||
Wella Company | |||
Related Party Transaction [Line Items] | |||
Accounts receivable, related parties | 78.4 | ||
Amount due from related parties | 0.3 | ||
Accounts payable | 7.6 | ||
Share-based compensation expense (income) | 0.7 | 1.7 | |
Sublease income | 2.1 | 2.4 | |
Wella Company | |||
Related Party Transaction [Line Items] | |||
Other noncurrent liabilities | $ 34.5 | ||
Wella Company | |||
Related Party Transaction [Line Items] | |||
Ownership percentage | 25.90% | 25.90% | |
Wella Company | Transition Services Agreement Fees | |||
Related Party Transaction [Line Items] | |||
Revenue from related parties | $ 1 | 0.8 | |
Wella Company | Related Party Transaction, Other Fees | |||
Related Party Transaction [Line Items] | |||
Revenue from related parties | $ 2.3 | $ 2.1 |
SUBSEQUENT EVENTS (Details)
SUBSEQUENT EVENTS (Details) - USD ($) $ / shares in Units, $ in Millions | Oct. 05, 2023 | Sep. 28, 2023 | Sep. 30, 2023 | Jun. 30, 2023 |
Subsequent Event [Line Items] | ||||
Common stock, shares issued (in shares) | 954,500,000 | 919,300,000 | ||
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||
Common Class A | ||||
Subsequent Event [Line Items] | ||||
Common stock, par value (in dollars per share) | $ 0.01 | |||
Euronext Paris Public Offering | Common Class A | ||||
Subsequent Event [Line Items] | ||||
Common stock, shares issued (in shares) | 33,000,000 | |||
Common stock, par value (in dollars per share) | $ 0.01 | |||
Net proceeds from issuance of Class A Common Stock | $ 348.5 | |||
Subsequent event | Brazilian Credit Facilities | ||||
Subsequent Event [Line Items] | ||||
Repayments of long-term debt | $ 31.9 |